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Abstract 
  
Hypertension, also referred as high blood pressure, is a chronical condition that affects 
nearly 25% of adults worldwide. The increasing prevalence of this illness has contributed to 
the pandemic of cardiovascular and renal diseases, which are responsible for a large 
number of deaths every year [1]. Therefore, it is fundamental to develop new 
antihypertensive drugs, in order to control and prevent the complications associated with 
high blood pressure. 
The Renin-Angiotensin System (RAS) is the major regulating system of the blood 
pressure and it consists of a two-step cascade. Firstly, the aspartic protease renin cleaves 
its only known substrate, angiotensinogen, in a rate limiting step, leading to the formation of 
the decapeptide angiotensin I (Ang I). Secondly, Ang I is transformed by angiotensin-
converting enzyme (ACE) to produce the octapeptide angiotensin II (Ang II), which binds to 
angiotensin II receptors (AT receptors) and mediates the blood pressure control. Effective 
antihypertensive drugs involving different RAS targets have already been developed. 
However, it is believed that the inhibition of renin would offer better results in blood pressure 
control, due to its specificity for only one substrate and the fewer adverse treatment side 
effects [2, 3].  
Therefore, the main goal of the present work is to describe, with computational 
methods, the atomistic details of the catalytic mechanism of human renin, to allow future 
studies on its inhibition. In order to achieve the purpose of this work the initial system (renin 
+ angiotensinogen) was divided in two layers that were studied at different theoretical levels 
(Density functional theory (DFT) and Molecular Mechanics (MM)). The geometries were 
optimized with the ONIOM methodology, at the B3LYP/6-31G(d):Amber) level. The energies 
of the stationary points were recalculated with single-point calculations, using a large basis 
set (6-311++G(2d,2p)) and a progressive increase in the number of atoms in the DFT layer. 
Molecular dynamics (MD) simulations were also performed in order to understand the 
behavior of the system along the time.  
Our results suggest that the angiotensinogen hydrolysis by renin occurs by an acid/base 
mechanism, through three elementary steps. It begins with the formation of a stable gem-
diol intermediate, followed by the scissile bond nitrogen protonation and it ends with the 
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completely cleavage of the peptide bond. The final reaction products are two peptides with 
carboxylic acid and amine extremities.  
We observed that the formation of the gem-diol intermediate is rate limiting, with a 
barrier near 20   kcal.mol-1. We also conclude that the residues around the active center 
greatly influence the catalytic mechanism of this enzyme. In addition, we also confirm that 
human renin catalytic mechanism is very similar to the mouse one [4]. 
The data obtained in the present work provides important clues about renin catalytic 
mechanism, which will enable further studies on its inhibition and, consequently, the 
development of new antihypertensive drugs.  
 
 
Key words: Hypertension, Renin Angiotensin System, Renin, Angiotensinogen, 
Catalytic Mechanism, Computational methods, ONIOM 
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Resumo
1
 
 
A hipertensão arterial, também conhecida como pressão sanguínea elevada, é uma 
doença crónica que afeta cerca de 25% da população mundial. A prevalência desta 
condição patológica tem contribuído para um aumento significativo de doenças 
cardiovasculares e renais, sendo estas responsáveis por uma grande percentagem de 
mortes todos os anos [1]. Tendo isto em conta, de forma a controlar esta condição e a 
prevenir possíveis complicações a ela associadas, torna-se fundamental o desenvolvimento 
de novos fármacos anti-hipertensivos que apresentem uma melhor resposta, face aos já 
existentes. 
 O sistema renina-angiotensina (RAS) é o principal sistema de regulação da pressão 
sanguínea e consiste numa cascata que pode ser resumida em dois passos. A primeira 
enzima envolvida nesta cascata é uma protease aspártica, a renina, sendo esta 
responsável pela clivagem do angiotensinogénio, o seu único substrato conhecido. Este é 
um passo limitante de toda a cascata e origina a formação do decapeptido Angiotensina I 
(Ang I). Num segundo passo, a Ang I é clivada pela enzima conversora da angiotensina 
(ACE) levando à formação do octapeptido angiotensina II (Ang II) que, por sua vez, interage 
com os recetores de Ang II, mediando, assim o controlo da pressão sanguínea. Existem no 
mercado vários fármacos que atuam sobre diferentes alvos do RAS, no entanto, acredita-se 
que o melhor alvo a inibir nesta cascata será a enzima renina, dada a sua especificidade 
para apenas um substrato e, uma vez que a sua inibição parece estar associada ao 
aparecimento de menos efeitos adversos [2, 3] .  
 Tendo isto em conta, o principal objetivo do presente trabalho passa por tentar 
descrever, através de metodologia computacionais e com detalhe atomístico, o mecanismo 
catalítico da enzima renina de humano, de forma a permitir e facilitar futuros estudos da sua 
inibição. Sendo assim, de forma a atingir este objetivo, o sistema em estudo foi divido em 
duas camadas que, por sua vez, foram estudadas com diferentes níveis teóricos (Teoria do 
funcional de densidade (DFT) e mecânica molecular (MM). As geometrias foram otimizadas 
com o método ONIOM com nível teórico B3LYP/6-31G(d):Amber. Nos pontos estacionários, 
                                               
 
 
1
 As abreviaturas usadas neste resumo derivam do termo em inglês 
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as energias forma recalculadas usando uma base de funções maior (6-311++G(2d,2p)) e 
incluído, progressivamente, na camada DFT um maior numero de átomos. Foi ainda 
realizada uma simulação de Dinâmica Molecular, com o intuito de perceber o 
comportamento do sistema ao longo do tempo. 
 Os resultados obtidos sugerem que a hidrólise do angiotensinogénio, pela enzima 
renina, ocorre através de um mecanismo acido-base, baseado em três passos elementares. 
Num primeiro passo, ocorre a formação de um intermediário gem-diol, seguida por um 
segundo passo de protonação do azoto da ligação a quebrar. Num terceiro, e último passo, 
ocorre a clivagem completa da ligação peptídica, sendo os produtos finais da reação dois 
péptidos com extremidades ácido carboxílico e amina. 
 Pode ainda ser verificado que a formação do intermediário gem-diol é limitante da 
velocidade da reação e que está associada a uma barreira energética de cerca de 20  
kcal.mol-1. Conclui-se ainda que os aminoácidos em torno do centro ativo parecem 
influenciar, de forma significativa, a energia associada a esta reação. Para além disso, 
verificou-se, ainda, que o mecanismo pelo qual a enzima humana cliva o seu substrato é 
semelhante ao seguido pela enzima de ratinho [4].   
 Os resultados obtidos neste trabalho contém informações essenciais sobre o detalhe 
do mecanismo da renina, que poderão ser úteis em futuros estudos de inibição desta 
enzima e, consequentemente, no desenvolvimento de novos fármacos anti-hipertensivos. 
 
Palavras-chave: Hipertensão, Sistema Renina Angiotensina, Renina, 
Angiotensinogénio, Mecanismo Catalítico, Métodos Computacionais, ONIOM
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CHAPTER 1 
INTRODUCTION 
   
“Silent killer, public health crisis” 
World Health Organization (WHO) 
  A global brief on hypertension – 2013  
 
1.1 Introductory note 
This work is being developed as part of a project with the title "New drugs for 
hypertension”. One of the initial goals of this project is the study of the enzyme renin as a 
target for the control of hypertension. As such, this dissertation will describe the catalytic 
mechanism of this enzyme. 
In this introductory chapter a brief review of the literature on some key topics useful for 
this work, will be made. Multiple subjects will be discussed, since the blood pressure, renin-
angiotensin-aldosterone system, to the antihypertensive therapy currently used. A special 
attention will be given to the crucial biological role of the enzyme renin in blood pressure 
control, its structural analysis, and its mechanism as an aspartic protease. Renin will be 
analyzed according to a systemic and biological vision and subsequently by a molecular and 
atomic point of view. Also in this chapter the enzymatic catalysis and the rational 
development of new drugs will be addressed, as well as the importance of Theoretical and 
Computational Chemistry as an essential tool for their study. 
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1.2 Hypertension  
Hypertension, or high blood pressure, is an important worldwide public health challenge 
because of its high incidence (more than 25% of adults worldwide) and association with 
risks of cardiovascular and kidney diseases. It has been identified on the ranking of higher 
risk factor for mortality and a disease that causes disability-adjusted life-years [1]. 
Hypertension is a chronic medical condition in which blood pressure in the vessels is 
elevated. The term blood pressure usually refers to the arterial pressure of the systemic 
circulation and it can be summarized by two measurements, systolic (when muscle’s heart is 
contracted) and diastolic (when muscle’s heart is relaxed), which corresponds to a maximum 
and a minimum pressure, respectively. Hypertension is said to be present when the blood 
pressure is persistently above 140 mmHg for maximum pressure and above 90 mmHg for 
minimum pressure. The statistic studies predict that in 2025 about 1.5 billion of people will 
have hypertension, which corresponds to an increase of 60% on the actual number. This 
increasing prevalence of hypertension worldwide has contributed to the pandemic presence 
of cardiovascular diseases that are responsible for 30% of all worldwide deaths [5, 6]. 
 Interventions that have proven effective in hypertension include weight loss, reduced 
intake of dietary sodium, moderate alcohol consumption, modification of eating habits and 
increased physical activity. However, sometimes these prevention measures are not 
sufficient, and secondary prevention efforts require a detection, appropriate treatment and 
correct control of hypertension. Furthermore, in spite of the enormous advances in 
antihypertensive drug therapies, the number of people with uncontrolled hypertension has 
continued to rise and, thus there is a huge need to improve these therapies [7, 8]. 
The increasing number of patients with hypertension is also attributed, in part, to the 
growing problem associated to risk factors such as obesity and diabetes. Despite its 
prevalence, only 5% of patients with hypertension have an identifiable cause [9].  
 Hypertension is a product of dynamic interactions between multiple factors: genetic, 
physiological, environmental and psychological factors. Autonomic nervous system and 
kidney are the major drivers of hypertension, and recently some reviews reveal that the 
immune system play also an essential role in the hypertension pathophysiology [10, 11]. 
Independent of the organ system involving in blood pressure elevation, it is clear that 
modifications in vascular function and structure are paramount in a physiological point of 
view. At the molecular level, abnormal signal transductions are responsible for modifying 
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cellular function involving different signaling pathways, such as phospholipase C, inositol 
phosphate, diacylglycerol, mitogen-activated protein kinase, tyrosine kinases 
/phosphatases, Rho kinases, transcription factors and NAD(P)H oxidase-derived reactive 
oxygen species. These important signaling pathways are stimulated by pro-hypertensive 
peptides like angiotensin II (Ang II) through their interaction with membrane associated G 
protein-coupled receptors [9, 12] . The Ang II molecule is the final product of the renin-
angiotensin system (RAS) that is the main regulator system of blood pressure. The next 
section will discuss this system, its constituents, regulation and importance.  
 
1.3 Renin-Angiotensin System 
The RAS is the master regulator of blood pressure and fluid homeostasis. This is an 
endocrine system and it is activated by various signals including the reduction of blood 
pressure, decrease in circulating blood volume and plasma-sodium concentration [13].  
As representing in Figure 1, in a summary view, this system is a multi-enzymatic 
cascade that starts with angiotensinogen hydrolysis. This protein is cleaved in two steps, 
first by renin and then by angiotensin converting enzyme (ACE), resulting in two sequential 
peptides, the angiotensin I (Ang I) and angiotensin II (Ang II).  
The appropriate activation of the RAS is essential for preventing circulatory collapse 
and maintaining fluid balance. A deregulation or a persistent RAS activation leads to a blood 
pressure increase. 
 
1.3.1 Renin, Angiotensinogen and Angiotensin I  
 The first step of RAS  
 The synthesis and release of renin are the key and early steps of the RAS cascade. In 
spite of the very early discovery of renin, in 1898, by Tigerstedt and Bergman [14], we only 
have recently gained a deeper understanding of the mechanisms responsible for its 
synthesis and release [15]. Human renin is a 340 residues protease and it can be secreted 
by two cellular pathways: 1) a regulated way with secretion of mature renin or 2) a 
constitutive way with secretion of pro-renin. Mature renin is secreted into the blood stream 
only from juxtaglomerular cells of the kidney, in response to different cellular stimuli: a 
decrease of arterial blood pressure detected by baroreceptors, a decrease in sodium 
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chloride levels in the nephron’s ultra-filtrate or sympathetic nervous activity, acting through 
β1 adrenergic receptors. On the other hand, the precursor of renin, pro-renin can be 
synthetized, not only in juxtaglomerular cells, but also in other tissues like adrenal, collecting 
duct, eyes, Müller cells, ovary, theca cells, uterus, myometrium, placenta, chronically cells, 
testis and submandibular gland.  
Angiotensinogen, mainly expressed in the liver, is cleaved by renin to release Ang I in plasma. Then, ACE metabolizes Ang I to 
Ang II, which can also be converted by other non-ACE pathways. This peptide interacts mainly with the AT1 receptors in 
numerous organs such as kidneys, heart and vessels, and it is responsible for the increase of blood pressure. This system can 
be inhibited by renin inhibitors, ACE inhibitors or AT1 receptor blockers (antagonists). 
 Renin is a member of the well-known family of aspartic proteases and it is responsible 
for the control of the first and rate-limiting step of RAS. This enzyme cleaves the 10 amino 
acids from the N-terminus of angiotensinogen, between Leu10 and Val11, to form Ang I.  
 Angiotensinogen is the only known physiological substrate for renin. In that way, renin 
has an essential and extremely specific role in RAS, in contrast to the ACE, as we will see 
later. 
Heart 
Vessels Kidney 
Renin Inhibitors 
ACE Inhibitors 
AT1 receptor antagonists 
Non-ACE pathways 
Figure 1. Classical renin-angiotensin system 
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Human angiotensinogen is a 452 residues long peptide mainly produced in the liver. It is 
also produced by other tissues as brain, immune system and kidney, but in very small 
quantities. RAS is regulated by a negative feedback and, therefore, plasma angiotensinogen 
levels are increased by a decrease in the Ang II levels. In addition, plasma corticosteroid, 
estrogen, and thyroid hormones levels also promote an increase of angiotensinogen levels 
[16]. 
 The cleavage of angiotensinogen by renin leads to the generation of both Ang I and 
des(Ang I)-angiotensinogen that corresponds to the remaining residues of angiotensinogen 
(more than 95%). This portion doesn’t have any associated biological properties to date.  
 It is well known that renal renin is secreted into plasma to cleave angiotensinogen 
release from liver and no other function is associated with this enzyme. In addition to renin, 
other enzymes such as cathepsin D or G, pepsin, tonin, tripsin, have been demonstrated to 
convert angiotensinogen into Ang I. However, these enzymes are abundant only in specific 
tissues or in some specific cell types and only have this kind of activity under strict 
conditions. Therefore, they do not have any significant impact on the systemic production of 
angiotensinogen peptides [17]. 
 The plasma concentration of angiotensinogen in humans is approximately 1 μM [18], 
which is close to the Michaelis-Menten constant (KM) of renin (1.25 μM) [19]. This indicates 
that both angiotensin and renin concentrations are important for the rate of Ang I generation. 
The Ang I molecule, resulting from the first step of RAS, after the cleavage of 
angiotensinogen by renin, appears to have no biological activity. It exists only as a precursor 
to Ang II formation. 
 
1.3.2 Angiotensin Converting Enzyme and Angiotensin II  
 The second step of RAS  
 ACE is a zinc dependent carboxyl dipeptidase. It is responsible for the cleavage of 2 
residues from the C-terminus of inactive Ang I and it generates the Ang II, in the classical 
RAS axis (Figure 1).  
The Ang II levels are also detectable in the ACE gene knockout mouse, which is 
indicative that enzymes other than ACE may contribute to Ang II formation. However, these 
studies also show that Ang II formation predominantly occurs via ACE [20, 21]. Along with 
Ang II, ACE also cleaves other peptide substrates, including the vasodilator peptide 
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bradykinin, which is degraded to an inactive peptide [22, 23] . Recently, ACE has also been 
implicated in the regulation of the immune system [24]. 
 In the non-classical RAS system pathway another bioactive angiotensin, Ang-(1-7), and 
an ACE homologue, ACE2, add further complexity to the proteolytic cascade. This path is 
less efficient and it consists in a first hydrolysis of Ang I, by ACE, to form Ang-(1-9), a 
peptide that is not known to have biological activity. Then, this peptide can be converted to 
Ang (1-7). ACE2 can also cleave directly Ang II to form Ang-(1-7). This last peptide has 
important biological activities due to its cardiovascular and baroreflex actions counteract 
those of Ang II [22, 25, 26].  
Although we cannot set aside the existence and importance of these new pathways, 
they will not be subjects of the present work. Ang II peptide is then the main and higher 
concentrated product of this second step of RAS. This is an active peptide that binds to the 
angiotensin receptors to perform their functions, as we will see in the next sub-section. 
 
1.3.3 Angiotensin receptors  
 The third step of RAS  
The actions of Ang II are mediated by specific populations of Ang II receptors. It is 
known that Ang II interacts at least with two distinct Ang II receptors subtypes, designed by 
AT1 (Angiotensin receptors type 1) and AT2 (Angiotensin receptors type 2). These subtypes 
of receptors can be distinguished and characterized according to inhibition by specific 
selective antagonists. There are also other subtypes of angiotensin receptors (AT3 and AT4) 
that have already some described functions. However, their activities and behavior are still 
poorly understood and characterized.  
 The main known biological actions of Ang II are the regulation of blood pressure, 
release of aldosterone, electrolyte and water balance, stimulation of sympathetic 
transmission, cellular growth. All of them are exclusively mediated by its interaction with the 
AT1 receptor [27-29]. The AT2 receptor, in turn, provides a counter regulatory role to AT1 
receptor over activity. Recent evidences suggest also that AT2 receptor exhibits favorable 
organ protection in the context of the heart, kidney and brain, mediating anti-proliferation, 
apoptosis and differentiation [22, 29, 30].  
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 When Ang II binds to the AT1 receptor, which belongs to the G protein-coupled receptor 
superfamily, typically activates phospholipase C (coupled to a Gq protein) and leads to an 
increase in intracellular inositol 1,4,5-triphosphate and intracellular calcium. These 
intermediates are responsible for vasoconstriction effects and sodium and water retention. 
Downstream, protein kinase C, proteins as Ras and RhoA and tyrosine kinase cascades are 
amplified, affecting members of the mitogen-activated protein kinase family (ERK1/2 and 
p38) and JAK-STAT pathways leads to vascular and cardiac effects [31]. 
AT1 receptors are located in the brain, adrenal cells, heart, vasculature and kidney. In 
blood vessels its activation by Ang II causes vasoconstriction leading to an increase in 
peripheral vascular tone and systemic blood pressure [29, 31, 32].  
 Contrarily to the AT1 receptors, the signaling pathway mediated by AT2 receptors leads 
to inactivation of ERK1/2, opening of potassium channels and inhibition of T-type calcium 
channel. Although various signaling pathways have been assigned to the AT2 receptor, it still 
not clear which of these is the most important.  
 In summary, Ang II is a multifunctional hormone that exerts diverse physiological effects 
and their actions are mainly mediated by AT1 and AT2 receptors, leads to blood pressure 
effects. 
 
1.4 Antihypertensive Agents 
 Drugs that inhibit RAS are gaining increasing popularity as initial medications for the 
management of hypertensive patients. Other antihypertensive agents are diuretics, beta 
adrenergic receptors blockers and calcium antagonists. Antihypertensive agents are used 
as monotherapy only in a small number of patients. The majority of people require two or 
more agents. 
 
1.4.1 Diuretics 
Diuretics, such as thiazides or related drugs, are some of the most frequently employed 
antihypertensive agents. The mechanism of action of these agents is related to the ability to 
increase sodium excretion as a result of binding to the thiazide receptor in the kidney. This 
therapeutic have, however, some side effects associated such as hypoatremia, 
hypokalemia, impotence and diabetes [33]. 
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1.4.2 β-blockers 
 Other therapeutic agents are the β-blockers that have been used for more than 30 
years. Some of the β-blockers are selective for β1 adrenergic receptors, others are non-
selective. Bradycardia, atrioventricular block or arrhythmias are normally associated to β-
blockers. They may also adversely affect the lipid profile with increase of triglycerides in 
serum and are associated with diabetes. The mechanism of action of β-blockers may 
depend on the reduction in cardiac output [33-35]. 
 
1.4.3 Calcium channel blockers 
 The calcium channel blockers can also be used as antihypertensive agents. They act as 
peripheral vasodilators as they block the entry of calcium through voltage dependent 
calcium channels and they include dihydropyridines and non-dihydropyridines. These 
agents induce oedema, flushing and sometimes headache and palpitations [36] . 
 
1.4.4 Vaccination 
 An old concept that has now resurrected is the use of vaccination to treat hypertension 
[37]. Some studies shows that a vaccine that induces antibodies against Ang II has yielded 
promising results in terms of blood pressure reduction [32]. However, the specificity and 
controllability of this kind of treatment needs to be evaluated. 
 
1.4.5 RAS inhibition 
The drugs that act in RAS system are also used as antihypertensive drugs. The 
pharmacological inhibition of classical RAS can be achieved through 3 different basic 
mechanisms, like we can see in Figure 1: 
1) Inhibition of Ang I generation from angiotensinogen. This can be achieved by direct 
inhibition of renin. 
2) Inhibition of Ang II generation from Ang I. This can be achieved through inhibition of 
ACE that, as we saw previously, is responsible for the formation of the octapeptide 
Ang II.  
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3) Inhibition of the action of Ang II at the level of its receptors. 
 
1.4.5.1 Renin inhibitors 
 The most logical point to block pharmacologically the RAS is the rate limiting step 
catalyzed by renin enzyme. Intervention at this point is more specific than ACE inhibitor or 
AT1 antagonists, because almost any angiotensin peptide can be generated, and no other 
peptide system would be affected. The renin inhibitors, due to its advantages, have been 
studied and developed decades ago, but the first commercialized renin inhibitor, the 
aliskiren, came onto the market recently [38]. Aliskiren blocks the RAS at the origin of the 
cascade inhibiting the generation of Ang I, and consequently the generation of Ang II. As the 
main goal of this work is the study of the catalytic mechanism of renin, to allow future studies 
on its inhibition, it is essential to understand its role, and therefore more emphasis to this 
enzyme and its inhibitors will be given later. 
 
1.4.5.2 ACE inhibitors 
 The first RAS inhibitor was an ACE inhibitor. Its intervention began in 1960’s with the 
discovery of venom of the snake Bothrops jararaca, which contains a substance that inhibits 
ACE. By modelling the active site of ACE, several new drugs that potentially bind this site 
were designed, and the first orally available ACE inhibitor was captopril [39]. Today more 
ACE inhibitors are available on market. These drugs proved to have a strong beneficial 
effect on morbidity and mortality in congestive heart failure and renal diseases. As we 
mentioned before, ACE is also a bradykinin degrading enzyme, therefore its inhibition also 
increases bradykinin concentration that is a vasodilator peptide. It has also been show, by 
other studies, that bradykinin potentiation is involved in the cardio and renal protection. 
However, this peptide may also be the major reason for adverse side effects of these 
inhibitors, as cough and angioedema [33]. 
 
1.4.5.2 AT1 receptor antagonists 
 A third group of drugs that interfere with RAS are specific antagonists for the AT1 
receptor. The first example of this class was losartan, which was followed by several other 
sartans. These drugs exert a more complete angiotensin blockade because other pathways 
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of angiotensin generation, such as  cathepsins, tonin or chymase, that are not affected by 
ACE inhibitors, become ineffective by AT1 antagonism. These drugs are also more specific 
for the RAS, than ACE inhibitors, because other peptide systems are not affected. The 
compensatory increase in renin concentration after AT1 blockade leads to an accumulation 
of Ang II, which activates the AT2 receptor. However, it is yet unknown whether this AT2 
stimulation often followed by bradkynin generation that is involved in the action of AT1 
antagonists [32, 40]. AT1 blockers and ACE inhibitors work by different ways and both have 
effects on lowering the blood pressure, however, ACE inhibitors are currently best 
documented then AT1 receptor antagonists. The choice of the best drug depends also on 
the patient. 
The similarities and differences between renin inhibitors, ACE inhibitors and AT1 
antagonists are summarized on the Table 1. In this table, it is evident that the renin inhibition 
is the most rational target to control the RAS system and consequently the blood pressure.  
It is important to refer that by inhibiting ACE or blocking the AT1 receptors, the negative 
feedback control, exerted by angiotensin II in the renin concentration, disappear and 
consequently an elevation on plasma and tissue renin activities are observed. Renin 
inhibition leads also to an increase on renin secretion and production but, in contrast to 
others RAS blockers, the newly release active renin is immediately neutralized by inhibitors 
present in the systemic circulation [41]. 
 
Table 1.Similarities and differences between Renin Inhibitors ACE inhibitors and  AT1 receptors antagonists. 
(+) symbol represents an increase of concentration and (-) symbol corresponds to a decrease of concentration. This table was 
adapted from [16]. 
 
Renin Inhibitors ACE Inhibitors AT1  Antagonists 
Plasma Renin Concentration + + + 
Plasma Renin Activity - + + 
Angiotensin I - + + 
Angiotensin II - - + 
Bradykinin Unchanged + Unchanged 
AT1 Receptor Not stimulated Not stimulated Blocked 
AT2 Receptor Not stimulated Not stimulated Stimulated 
 
 
Making a point of the situation of what has been described hitherto, the hypertension 
was initially introduced as a concern disease due to its direct relationship with cardiac and 
renal diseases. Then, the main regulatory system of blood pressure (RAS) was briefly 
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presented, with some emphasis to the first step. Finally, the most common antihypertensive 
therapeutics was summarized. 
 From now on, the renin enzyme will be the main focus of this work. Its structure, 
function and inhibition will be discussed, due to this enzyme appears to be the most logical 
target for the development of new antihypertensive agents. 
 
1.5 Renin  
1.5.1 Relation between structure and function 
As previously mentioned the renin enzyme cleaves angiotensinogen to release the N-
terminal decapeptide Ang I.  Efforts into the elucidation of the molecular architecture of renin 
only succeed when they could be expressed and purified from recombinant sources. 
Renin (EC 3.4.23.15) is a mono-specific 340-residues protease polypeptide, with 
approximately 40 000 KDa that belongs to aspartic protease superfamily  [42].  
Structurally, renin consists of 2 lobes with different residues sequence but similar 
structure. These lobes fold mainly β sheet conformation, with a deep cleft between them that 
is characteristic from the aspartic proteases class. The residues around the cleft correspond 
to the active site and it accommodates seven residues from its substrate, angiotensinogen 
(Figure 2C).  It has been shown that the minimal substrate sequence that has good affinity 
and reactivity is an octapeptide constituted by the residues between 6 and 13 of 
angiotensinogen. The catalytic activity of renin is due to two aspartic acid residues (32 and 
215 or 38 and 236 in pepsin and human renin numbering, respectively), each located in a 
single lobe and held coplanar by a network of hydrogen bonds involving the surrounding 
main chain and conserved residues side chain groups. Like happens in other aspartic 
proteases, there are a water molecule in  the active center of renin that hydrogen bonding 
with all four carboxyl oxygen atoms of aspartic catalytic dyad, and it has been implicated in 
catalysis. It has been suggested that this water molecule is partly displaced near the 
substrate and it is polarized by one of the catalytic aspartate residues.  
The structure of renin has both hydrophobic and hydrophilic residues. The hydrophobic 
ones are more concentrated inside the protein and form hydrophobic cavities in the active 
site [41, 43, 44]. 
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A) Cartoon representation of human renin. B) Cartoon representation of human angiotensinogen interacting with the deep cleft 
of renin (C). The structure was adapted from 2X0B PDB file. 
 
In the same way, as in the other aspartic proteases, renin possesses a flexible “flap” 
constituted by residues in a β-hairpin that is close to the active site and allows cleft covering. 
Recently, the dynamical behavior of this flap was studied by Molecular Dynamics (MD) 
simulations, and it was verified that it oscillates between open, semi-open and closed 
conformations could allow the binding of a wide range of inhibitors [45].  
The active site of renin was studied by other authors and it is composed of 8 sub-
pockets. The characteristics of each pocket was reviewed by Webb [46]. The S1 and S3 
pockets forms a continuous and hydrophobic cavity and they contains the S3sp sub-pocket, 
which is specific to renin and unique among the aspartic proteases and have also 
hydrophobic and hydrophilic characteristics. The S2 and S4 pockets have also hydrophobic 
characteristics. The S1’ are predominantly hydrophobic, while S2’ have polar character 
(hydrophilic). This kind of information has a very important role for the future design of new 
renin inhibitors.  
It is known that renin is very specific for its unique substrate and an important question 
that arises is that, if the main chains of proteases are conserved, how are the differences in 
Figure 2. Human renin structure complexed with its substrate 
A 
B 
C 
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specificities achieved? Probably the specificities derive from slight differences in the sizes of 
residues in the specific pockets (Sn) to complement the corresponding side chain of the 
substrate. For example some studies have predicted the specificity site S3 to be larger in 
renin than in other aspartic proteases and that a movement of a helix makes the pocket 
quite compact and complementary to aromatic rings. Therefore, the position of an element 
of secondary structure differs between renin and other aspartic proteases with important 
differences in the pocket specificity. As it happens in S3 pocket, the differing positions of 
secondary structure elements may also account for the specificities of the other pockets. 
Previous studies were also suggested that this high specificity is due to the rigidity of its 
binding pocket. However, the reason of the high renin’s specificity is still unknown [47, 48]. 
 
1.5.1 Proposed for Renin catalytic mechanism 
The main objective of this work is to clarity with atomistic detail the catalytic mechanism 
of human renin by a computational approach. The mechanism of action of other aspartic 
proteases such as HIV-1 protease, presinilin and β-secretase was previously studied with 
MD simulations and combined Quantum Mechanics and Molecular Mechanics calculations 
(QM/MM) [49-53]. All of these computational techniques will be discussed in the following 
chapter.  
There are proposals for the catalytic mechanism of renin but, its atomistic details remain 
unclear. Our group also published a proposal for the catalytic mechanism of mouse renin 
[4], but for the human enzyme, the mechanism has not been described yet. 
The proposal mechanism of action of human renin involves an acid-base mechanism as 
it was described for other aspartic proteases. One of two catalytic aspartic residues is 
protonated, whilst the other, with a negative charge, acts as a general base, activating a 
water molecule tightly bound between both aspartate residues. Then, the water molecule 
makes a nucleophilic attack on the carbonyl carbon of the scissile bond resulting in the 
formation of a tetrahedral gem-diol intermediate (Figure 3A-B). The second step involves a 
protonation of the peptidic nitrogen by one of the catalytic aspartate and a deprotonation of 
one of the gem-diol hydroxyl group by the other aspartate. Subsequently, this step leads to 
the cleavage of the peptidic bond (Figure 3C-D). 
 In the beginning of the reaction the two catalytic aspartate residues have an adjacent 
position and they have different pKa values, one being protonated and the other ionized at 
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neutral pH. This result was previously demonstrated by experimental and theoretical studies 
[54].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
A) Representation of the aspartic proteases active site with two Asp residues and a catalytic water molecule. In first step of the 
proposal catalytic mechanism a water molecule makes a nucleophilic attack on the carbonyl carbon of the scissile bond 
resulting in the formation of a gem-diol intermediate (B). C) In a second step, the nitrogen of the scissile bond is protonated by 
the catalytic Asp residue and this step ends with the peptidic bond cleavage (D). 
 It is also important to say that, in aspartic proteases, the residues around the catalytic 
center play an essential role in the catalytic mechanism. Furthermore a second conserved 
water molecule seems to have a structural role due to its participation in an H-bond network 
(Asp-Ser-W2-Tyr-Trp) that stabilizes the flap conformation during the catalysis [54]. 
However the role of this water molecule in the catalysis is still unknown. 
 
1.5.3 Development of renin inhibitors 
Like we mentioned before, the use of the drugs that inhibit the RAS system is an 
effective way to intervene in the control of hypertension.  Considering the higher specificity 
of renin, the inhibition of this enzyme has benefits by decreasing its activity without 
interference with other metabolic pathways [55]. 
Pepstatin was the first renin inhibitor. It was found to be a competitive inhibitor of most 
aspartic proteases. 
Figure 3. General proposal mechanism of amine bond hydrolysis by aspartic proteases. 
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Then, considering that it was widely recognized that direct renin inhibition held great 
therapeutic potential, the design of new molecules that interact with the catalytic center of 
renin has been studied. First generation of renin inhibitors were peptide analogues 
(peptidomimetics) of the amino-terminal sequence of angiotensinogen. These analogues 
contain the renin cleavage site which, with further chemical modifications, led to the 
development of compounds as CGP29387 that had greater stability and long duration 
action, but it only have effect in high doses [56]. The second generation of renin inhibitors is 
characterized by a molecular weight of a tetrapeptide such as enalkiren, CGP38560A, 
ramikiren and zankiren. When given orally, these compounds had low bioavailability (< 2%), 
a short half-life and weak blood pressure lowering activity [57]. Later, the aliskiren was 
discovered as an orally active renin inhibitor by Ciba-Geigy (now Novartis). After successful 
preclinical and clinical testing it was approved and commercialized [58, 59]. Actually, with 
the help of crystallography and molecular modeling, the substituted piperidine renin 
inhibitors have been developed. However, the majority of them are abandoned after 
preclinical tests and no one was approved until now [55]. The Aliskiren, the unique drug 
commercialized for renin, interacts with several binding pockets in distinct regions around 
the active site. In particular it was found to bind the S3sp specific sub-pocket. This inhibitor 
has been shown, in experimental and clinical studies, to be effective in lowering the blood 
pressure and in organ protection. The Aliskiren effects are similar to those of other RAS 
inhibitors and normally it is used in combination with other antiherpentensive drugs. 
Given the continuous prevalence of hypertension is still need to develop new drugs for 
this disease. With the advancement of computational techniques in enzymatic studies, the 
design of new effective drugs may be easier.  
 
1.6 Computational enzymatic catalysis and 
drug design  
The aim of this work involves the study of the catalytic mechanism of the renin enzyme. 
Therefore, a brief approach to enzymatic catalysis is also necessary in this introductory 
chapter. In fact, living cells and in turn multicellular organisms, depend on chemical 
transformations for every essential life processes. If these essential biochemistry reactions 
proceed at non catalyzed rates they are too slow (million years!) to sustain life. It is evident 
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that a very slow reaction cannot sustain life without some very significant rate enhancement. 
The enzymes are responsible for this enhancement and, therefore, enzymatic catalysis is 
essential for all life.  
 
1.6.1 The role of computational chemistry in enzymatic catalysis 
The first question to be asked is ‘What is the catalytic mechanism of a reaction?’ 
Establishing a mechanism of a reaction means identifying which groups in the protein are 
involved in the reaction, and clarifies their precise roles during catalysis. There are many 
experimental methodologies such as protein crystallography, NMR, site-directed 
mutagenesis, kinetics, isotopic labeling and spectroscopic those provide fundamental 
insights to the study of enzymatic catalysis. Research in the establishment of enzymatic 
mechanisms has suffered great advanced with new efforts in computational chemistry, 
which allows the atomistic description of all mechanistic details. 
Predicting an enzymatic catalytic mechanism is generally a long and complex job. A 
complete description involves the identification of reactants (R), intermediates (INT), 
transition states (TS) and products (P) along the reaction coordinate, as well as the free 
energies of activation and reaction for each of the reaction steps.  
In some cases, experimental methodologies allow the determination of the initial 
enzyme-substrate complex, the identification of some intermediates and the determination 
of the free energy of activation of the rate-limiting step. However, the structure of TS and the 
energies associated to them are impossible to determine by these techniques, because of 
the reduced lifetime of these species (10-13 seconds that corresponds to the time for a single 
bond vibration).  
On the other hand, computational methodologies offer opportunity to study with atomic 
detail the enzymatic mechanism, providing atomistic insight in very important processes. All 
these facts indicate that computational studies have an essential and very important role in 
mechanistic studies. They are able to correctly identify and describe in a structural and 
energetic view the Transition states, independently of their lifetime, which  complement the 
information obtained from experimental works [60-62]. In addition, computational 
methodologies make possible the study of large systems, like enzymes, where the reactive 
region is only a small part of the system. Thus the remaining structure of the enzyme and its 
role as a modulator of the active center, either stabilizing or destabilizing along the potential 
energy surface (PES) is also evaluated. 
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To study the correct mechanism of an enzymatic reaction, we need to search for the 
minimum energy pathway in the PES of the study system. The realism and success of the 
computational data for a mechanistic pathway depends on the system’s Hamiltonian 
accuracy (the Hamiltonian will be explained latter), the sampling of the reactional space and 
the sampling of the conformational space [60, 63]. One of the key to elucidating the catalytic 
mechanism of an enzymatic reaction is the understanding of specific interactions between 
the substrate and its enzyme environment and their effect on the reaction rate.  
 
1.6.2 Rational drug design  
In drug discovery, enzymes are important as targets for new drugs (most part of drugs 
are enzyme inhibitors). The identification and description of enzymatic catalytic mechanisms 
add another dimension to structure based ligand design for enzyme targets. Modeling can 
also identify catalytically important interactions that could be exploiting in drug design. 
All chemical enzymatic reactions pass through an unstable structure called the 
transition state (TS) with is poised between the chemical structures of the substrates and 
products. Enzymes stabilize the TS of their reactions. By binding the TS more tightly than 
the substrates or the products, the enzyme is responsible for lower the energy barrier of the 
reaction. Consequently a TS analog will bind more tightly to the enzyme than either the 
substrates or the products, preventing them from binding to the enzyme and reacting. 
For aspartic proteases, like HIV-1 protease, there are many inhibitors that were 
obtained by drug design with TS analogs. Nowadays, HIV-1 protease inhibitors constitute 
around 40% of available drugs against HIV. Nearly all of them contain hydroxyethylene units 
as TS analog mimic. Thus, the design and success of HIV-1 protease inhibitors represent 
one of the most remarkable achievements of drug design [64].   
Due to rapid technological progress in chemistry, bioinformatics, structural biology and 
computer technology, studies of computer aided drug design play more and more important 
role in this respect. 
 
1.7 Purpose of the present work 
As mentioned before, RAS represents the most important regulating system of the 
arterial blood pressure. The renin enzyme, an aspartic protease, has an exclusive activity 
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and its determinant velocity on the RAS cascade makes it an ideal target for new 
antihypertensive drugs. Therefore, the main purpose of the present work is describing with 
atomistic detail, the catalytic mechanism of this human renin by computational methods. 
In addition, this study will also assess the role of a structural water molecule in the 
catalytic mechanism of this enzyme. Moreover, the role of residues around the active center, 
in the stabilization of the reaction intermediates, will also be evaluated. Finally, the influence 
of a mutated substrate, in the reaction catalyzed by renin, will also address. 
This kind of knowledge has a very important role in future drug design which will enable 
the control of the “silent killer” and the “public health crisis” that is hypertension.
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CHAPTER 2  
THEORETICAL BACKGROUND  
 
“The underlying physical laws necessary for the mathematical theory 
of a large part of physics and the whole of chemistry are thus completely 
known, (…) and the difficulty is only that the exact application of these 
laws leads to equations much too complicated to be soluble.” 
  Dirac, 1929 
 
2.1 Introduction                      
Theoretical chemistry aims to develop algorithms, methodologies and theories that 
explain and reproduce systems at atomic and molecular levels. When they are applied 
computationally, the methods of theoretical chemistry, seek the clarification of chemistry and 
biological systems at an atomistic level. 
If we wish to study the catalytic mechanism of an enzyme, as is the main purpose of this 
dissertation, we must use theoretical and computational methods. Computational 
biochemistry is able to predict results and deductions that are very expensive and time 
consuming when they are obtained experimentally. These methods are still able to interpret 
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experimental results and complement them, as well as suggest new interpretations for a 
better understanding of these results to clarify relevant doubts that may exist. Therefore, 
experimental techniques and theoretical techniques go hand in hand to try to explain 
chemical and biological problems at the molecular level.  
Since the discovery of the resolution of the Schrödinger equation for the hydrogen atom 
in 1926 [65], quantum mechanics has been increasingly used in an attempt to interpret and 
predict the electronic structure and behavior of bio/chemical systems. A great number of 
efficient computer programs has been developed, which try to study with increasing 
accuracy large size systems, such as biological enzymatic systems. Due to the fast progress 
of computing power, the application of these methods to the study of biological systems has 
been widely used and the results obtained have been more and more precise. Through 
computational methods applied to Biochemistry it is possible to determine individual 
properties of biological molecules such as reaction energies, reaction mechanisms, dipole 
moments, charge distribution, interaction between different molecules among others. Thus, 
Computational Biochemistry is an extended scientific area that can be combined with any 
other area of Biochemistry, promoting the development of useful applications in Chemistry, 
Biology or Medicine. For example, the clarification of enzymatic reaction with computational 
methods can be extremely useful for the rational design of new molecules/drugs to 
receptors or enzymes in order to control, or even cure, some diseases. 
Nowadays, Theoretical Chemistry methods are increasingly sophisticated and may be 
applied to more complex systems. Generally theoretical methodologies can be classified 
into four main categories: 
 
1. Ab initio methods 
2. Density Functional Theory (DFT) 
3. Semi-empirical methods 
4. Molecular Mechanics (MM) 
 
Ab initio methods do not include any empirical parameters in their equations, and they 
are only based on the laws of quantum mechanics (QM). They try to solve the equation of 
Shrödinger as accurately as possible through a strict set of mathematical approaches. 
Those methods potentially provide very accurate results. However, they require a high 
computational cost, and therefore, they are only used for small size systems. DFT methods 
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are also  quatum mechanical but they are bases on the total electronic density of the system. 
Semi-empirical methods maintain the quantum nature of the calculation, but, as the name 
suggests, parameters from experimental data can be introduced in the calculations. These 
methods are quite computationally inexpensive and rely on a series of approximations. MM 
methods are very useful when we have very large systems to study, as is the case of 
enzymes. In MM, the atom is the fundamental particle and classical mechanics laws are 
used to predict the behavior of the system, contrarily to the methods presented before. In 
that way, the MM force fields do not allow for an electronic description of the system and the 
description of bond breaking and forming is not possible. In addition to the methods 
presented previously, it is also possible to use hybrid methods in the study of large 
systems like enzymes. These include a combination of QM and MM methods, where the 
system is divided in two or more fractions and each part is calculated with one distinct 
method.  
In the following sections the computational methods used in this work, as well as their 
development and application, will be reviewed briefly. The first section of this chapter will 
deal with the molecular mechanics and then another section will be dedicated to quantum 
mechanics  
 
2.2 Molecular Mechanics  
Molecular mechanics (MM) is a simplified approach to chemical problems. If we want to 
explore geometries, relative energies of conformers of the same molecule or study the 
behavior of docked substrates into active sites, MM methods are very effective tools.  They 
are based on classical mechanics and they are very useful to perform calculations on 
systems containing a significant number of atoms [66-68].  
In MM the smallest particle is the atom, which means that neither electrons nor protons 
are explicit considered and the potential energy depends only on the atom position. 
Molecules are treated as a set of charged point masses (the atoms) which are coupled 
together with springs. The total energy of a structure is calculated using an analytical 
function that sums the individual energy terms. Generally, the function includes bond 
stretching, bond angle bending, torsion, and non-bond interaction terms. 
MM falls apart when one wants some deeper understanding of the system. If we are 
studying a reaction mechanism profile, breaking or forming bonds, we cannot use the MM 
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approach. The breakage and formation of bonds is out of scope of MM [69]. Despite some 
incapacities, MM is a very powerful method and it is extensively used in computational 
biochemistry as it allows the treatment of very large systems. 
The parameters that are used in MM energy calculations are derived from databases of 
structures developed by experimental and quantum mechanical methods. These parameters 
and equations used to describe a system in MM are referred as a force field.   
 
2.2.1 Basic Theory – The force field energy 
The MM energy expression consists of a simple algebraic equation for the energy of a 
compound and it does not use a wavefunction or the total electron density. The constants 
used in these equations are obtained from experimental data or ab initio calculations, as 
referred previously. One of the ideas of molecular mechanics is the transferability of 
parameters. In other words, transferability hypothesis suggests that the properties of atoms 
in large molecules can be deduced from the study of representative set of small molecules. 
The derived energy parameters are then transferred to proteins or other larger and more 
complex molecular systems. Roughly speaking, the transferability implies that the bond 
lengths, angles (etc.) are the same in small “test” molecules as well as in much larger 
proteins. In order for the transferability of parameters to be a good description of the system, 
force field use atom types. This means that a sp3 carbon will be described by different 
parameters than a sp2 carbon, and so on [70].  
Since MM does not take into consideration properties that depend on electronic 
distribution, several valid assumptions have to be taken into account. The Born-
Oppenheimer approximation makes it possible to express the Hamiltonian as a function of 
the nuclear variables, since the motion of the electrons is averaged out. Therefore the 
classical potential energy tries to describe as accurately as possible the energy of the 
system using a rather simple model of the interactions within a system from processes such 
as stretching of bonds, the bond angle bending, dihedral torsion terms, the rotation around 
single bonds (intramolecular forces) and non-bonding interactions within a system with 
contributions such as Coulombic and Van der Waals interactions. 
Therefore, the potential energy function can be described as a mathematical equation 
that allows for the potential energy of a chemical system to be calculated as a function of its 
three dimensional structure (Equation 1). The potential energy of a system can be written as 
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a sum of terms (force field) that describe the energy required for the molecule to move and 
interact with its environment in a specific manner:  
  
 (  )                                                            
Equation 1. Force field potential energy 
 
Where        represents the potential energy required for stretching a bond between 
two atoms,         represents the potential energy function for angle bending,             is 
the torsional energy for dihedral angles. Finally, the terms               and          
describe the non-bonded atom-atom interactions. The                describes the energy of 
the repulsion and attraction between atoms that are not directly bonded, and the          
represents the electrostatic potential energy between all atom pairs separately by three or 
more bonds. 
A MM force field gives to each atom an atom type that depending on the atomic number 
and its molecular environment. Different force fields have different atom types. One of the 
most popular force fields is AMBER (Assisted Model Building with Energy Refinement) [71] 
within the AMBER software, which was used in the present work and it is essentially used 
for describing polypeptides, proteins and nucleic acids. There are other force fields specific 
for biomolecules such as CHARMM (Chemistry at HARvard Molecular Mechanics) [72] and 
OPLS-AA (Optimized Potential for Liquid Simulations) [73]. In addition, there are different 
force fields that possess parameters to describe other type of molecules such as 
carbohydrates and lipids.  
In the next subsections, each term of the force field potential energy equation (Equation 
1) will be summarized. 
  
2.2.1.1 The Stretch bond energy 
The potential energy of bond stretching corresponds to the energy associated with the 
elongation of a bond. It is given as a sum of potential energies for stretching each bond 
within the molecule under study. The simplest approach to calculate it is to use a harmonic 
potential centered at the equilibrium bond length (Equation 2). 
 24 FCUP/ICBAS 
Elucidating the catalytic mechanism of human renin with hybrid QM/MM studies   
  
 
  
           ∑
 
 
   (       
 )  
Equation 2. Bond Stretching potential energy  
  
The expression takes        as a quadratic function of the displacement of the bond 
length     from its equilibrium bond length    
 . In this expression, I and J represent the atom 
types of the atoms i and j in the molecule. The     constant and    
  length depend on the 
atom types that form the bond and they are contained in the force field parameters.  
 
2.2.1.2 The bending energy for angles 
The bending energy is the energy required to modify an angle past its equilibrium point. 
The potential energy of angle bending is taken as a sum of potential energies for bending 
each angle in the system, which is represented in the expression of Equation 3.  
 
             ∑
 
 
    (         
 )  
Equation 3. Bond bending potential energy  
 
Where the      represents the angle between the atoms i, j and k, and     
  is the 
reference value for the bond angle type IJK. 
 
2.2.1.3 The dihedral / torsion energy 
 The dihedral / torsion potential energy is taken as a sum of the terms                 over 
all atoms separated by 3 bonds. The expression that represents this term is described 
below: 
                  ∑
  
    
 
(     (        )) 
Equation 4. Dihedral angles potential energy  
  
Where   is the dihedral or torsional angle defined between the sequence of IJKL 
atoms. The dihedral angle is defined as the angle between bonds IJ and KL when they are 
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projected into the plane bisecting the JK bond. In the Equation 4,   represents the number 
of minima over 360º of the torsional potential and   determines the location of the minima. 
 
2.2.1.4 The van der Waals energy  
The van der Waals potential energy,              , is a non-bonded term and it is used 
for atom pairs, i and j, separated by three or more bonds. This term describes the repulsion 
and attraction between atoms that are not directly bonded.  
The               term is usually a sum of interactions involving all possible 1 and 4, 1 
and 5, 1 and 6 (etc.) atoms. It may be represented by the Lennard-Jones potential (Equation 
5). 
  
              ∑                       
                      [(
   
   
)
  
  (
   
   
)
 
] 
Equation 5. van der Waals potential energy  
 
The AMBER force field takes the                  as a Lennard-Jones potential 
(Equation 5) [74], in which     is the distance between the atoms i and j,     is the minimum 
potential energy attainable and      is the distance when the energy is zero. Figure 4 shows 
the graphical representation of the Lennard-Jones potential function for a better 
understanding. 
 
 
 
 
 
 
 
The figure is adapted from Essentials of Computational Chemistry-Theories and Models [67]. 
σij 
𝜀 
Rij 
VVan der Waals,ij  
Figure 4. The Lennard-Jones potential as a funtion of interatomic distance. 
21/6 σij 
 26 FCUP/ICBAS 
Elucidating the catalytic mechanism of human renin with hybrid QM/MM studies   
  
 
  
Figure 5. Representation of all interactions present in the potential energy expression (Equation 1). 
The Lennard-Jones potential contains a repulsive term, (
   
   
)
  
 which accounts for the 
electron repulsion. The 12th power dependence has no theoretical justification, and the 10 
exponential factor produce, indeed, better results. However, the computational calculation is 
faster in that way because that term can be calculated by squaring the second term with 
exponential 6  [67]. The second term, (
   
   
)
 
, represents an attractive part that corresponds 
to the London’s dispersion forces, in other words, the instantaneous dipole – induced dipole 
interactions. In summary, the Lennard-Jones potential is used to describe dispersion forces 
between separated atoms. 
 
2.2.1.3 The electrostatic energy  
The other term that also represents the non-bonded interactions is the electrostatic 
potential energy. The electrostatic potential can be written as a sum of electrostatic 
interactions involving all atom pairs separated by three or more atoms (Equation 6). 
 
          ∑                   
            
    
       
 
  
Equation 6. Electrostatic potential energy  
 
 The electrostatic potential between atoms i and j is described by a Coulombic term, 
where the qi and q2 represent the charges of the two atoms, the     represents the distance 
between them and    represents the dielectric constant of the medium. 
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2.2.2 Molecular dynamics 
Molecular Dynamics (MD) simulates the motion of system particles as a consequence 
of their interaction with other particles. 
Nowadays, the vision of proteins and nucleic acids as dynamic systems replaces the 
previous their view as static models. In that way, MD simulations are very important in the 
study of biological systems, because they are able to simulate the motion of some atoms 
that have essential biological functions. 
The MD method was first introduced by Alder and Wainwright [75] in the late 1950s. 
The first protein MD simulation appeared in 1977, with the simulation of the bovine 
pancreatic trypsin inhibitor [76]. After this 1st application on this small protein, advances in 
computer power, algorithmic developments and improvements in the accuracy of the used 
interaction functions, have established this method as an important and predictive technique 
to study dynamic processes at atomic resolution. MD simulations can provide the ultimate 
detail concerning individual partial motions as a function of the time. They can be used to 
clarify specific questions about the molecular properties of proteins and nucleic acids 
(structure, dynamics and thermodynamics), often more easily and atomistic detailed than 
experimental methods [77].  
In this method the simulation of a molecular system with the time, is given by the 
potential energy function presented previously, and the Newton second law or equation of 
motion. From the knowledge of the force on each atom of the system and its mass, it is 
possible to determine the acceleration of each atom in the system. Therefore, in molecular 
dynamics, the integration of the equations of motion, results in a trajectory that describes the 
positions, velocities and acceleration of each particle along time. When the position and 
velocities of each atom are known, the state of the system can be predicted at any time.  
To calculate a molecular dynamics trajectory, it is just necessary to know the initial 
positions of the atoms, an initial distribution of velocities and the acceleration. The initial 
position of the atoms is given by experimental structures obtained, for example, by X-ray 
crystallography. The velocities are assigned randomly from a Maxwell-Boltzmann 
distribution at the desired temperature. The other parameters are determined by the 
potential energy function.  
In order to obtain a satisfactory integration of the equations of motions, an adequate 
time step for the simulation must be chosen. To prevent some physical errors, the time step, 
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in which the forces are calculated, must be ten times smaller than the fastest process in the 
system. The fastest process in a simulation is normally the vibration of hydrogen atoms, 
which occur with a frequency of about 10 femtoseconds (fs) and a time step in the order of 1 
fs are necessary to describe these motions.  
In protein molecular dynamics studies, it is common to precede the simulation using 
explicit solvent molecules. The most typical water model used in the simulations is the 
TIP3P. The use of explicit water molecules brings some complications. While the atoms in 
the structure of protein are surrounded and bound by other atoms forming a cohesive 
structure, the particles near the boundaries (water molecules) can suffer large motions 
during the simulation. To solve this, a concept of periodic boundary conditions is employed, 
in which the main cell (protein, counter-ions and water molecules) is the central part of an 
infinite repetition of the identical cells in all directions. The movement calculated for the 
atoms in the original cell is replicated for the other cells. Thereby, the periodic boundary 
conditions are an efficient way to correct surface effects.  
 
2.3 Quantum Mechanics  
This subchapter deals with quantum mechanics and it will try to describe how its 
concepts can be useful in the enzymatic catalysis studies. 
Until the end of the nineteenth century, physics consisted essentially of classical 
mechanics, electromagnetism and thermodynamics. Classical mechanics was used to 
predict the behavior of the dynamics of material bodies and the study of radiation was 
provided by Maxwell’s electromagnetism. Matter and radiation were described in terms of 
particles and waves.  
 However, with Einstein relativistic theory and the development of the microscopic 
domain, the incontestable classical physics failed in providing the appropriate explanation 
for atomic and subatomic structures. Therefore, it became evident that the theories of 
classical physics cease at the microscopic level and new ideas had to be theorized in order 
to describe the structure of atoms and molecules. Many theories by Einstein, Planck, Bohr, 
Compton and De Broglie led to the definition of quantum mechanics. Quantum mechanics 
describes in an exact way the dynamics of all particles.  
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The wavefunction is the starting point for any discussion of quantum mechanics. The 
fundamental postulates of quantum mechanics describe microscopic systems as 
wavefunctions that completely characterize all physical properties of the systems. With the 
application of appropriate operators to the wavefunction, it is possible to determine 
observable properties of the system. The mathematical notation of this postulate is 
represented by Equation 7. 
 
       
Equation 7- Postulate of quantum mechanics 
Where   is an appropriated operator for some property of the system,   is a eigenvalue 
this property and  the wavefunction. 
 
2.3.1 The Schrödinger equation 
Mathematically, the Schrödinger equation is a function of an infinite space that maps all 
the possible states of a system. The time-dependent Schrödinger equation is represented 
by Equation 8: 
 ̂  (   )    
 
  
 (   )  
Equation 8. Time-dependent Schrödinger equation 
 
Where ̂  is the Hamiltonian operator,   is the wavefunction, i is the imaginary unit,   is 
h / 2 , q are the particle coordinates and t is time. With this simple expression it is possible 
to calculate the evolution of any system along the time just by applying the  ̂  operator to 
the .  
With the solutions of the Schrödinger equation it is possible to describe molecular, 
atomic and subatomic systems. In addition it is also possible to describe macroscopic 
systems or, in an ideal vision, the whole universe. Although this is an exciting idea, it does 
not solve all chemical problems. The present equation is not analytically solvable for more 
than two interacting particles. As Dirac said, in the transcript that we use at the beginning of 
this chapter:  
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 “…the exact application of these laws leads to equations much too complicated 
to be soluble.”  
Dirac, 1929 
  
Many approximations are required to make this equation solvable. In the non-relativistic 
case, the energy of a stationary state of a given number of atoms and electrons is given by 
the time independent Schrödinger equation. 
 ̂     
Equation 9. Time-independent Schrödinger equation 
 
In this expression the solutions and the total energy of an isolated system are constants 
and no parameters are time dependent. The Hamiltonian operator returns the system 
energy.  
This form of the Schrödinger equation also neglects relativistic effects. According to the 
theory of relativity, the mass of any particle has a significant change when this particle 
moves at velocities near the speed of light. This effect is only significant for heavier atoms 
(actinides and lanthanides) hence the inclusion of a relativistic term in the Hamiltonian is not 
necessary for biological studies. The time independent Schrödinger equation (Equation 9) is 
only a function of space coordinates (q) of the particles of the system. 
 
2.3.2 The Hamiltonian 
In quantum mechanics, the operators act on wavefunctions resulting into the same 
wavefunctions and the value of the physical properties that are associated with them. The 
Hamiltonian is an operator and it is associated with the total energy of the system. 
In the time independent Schrödinger equation (Equation 9) we treat stationary states 
(constant energy) and as a result,   is a function that, for atoms/molecules, only depends 
on nuclear and electronic positions. 
The Hamiltonian operator is given as a sum of kinetic ( ̂) and potential energy ( ̂)  
operators and, for atoms/molecules, it can be written as follows:     
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Equation 10. Hamiltonian operator expression 
 
The Hamiltonian is written in atomic units and A and B refer to the N nucleus, i and j to 
the M electrons, and      and    are the mass and atomic number of nuclei A, respectively.  
    represents the distance between nuclei A and B,     the distance between nuclei A and 
electron i and, finally the     represents the distance between electrons i and j. The  
  term 
is the Laplacian operator and is equal to    
  
  
  
  
  
   
  
  
 .  
As we can see in Equation 10, the Hamiltonian has five terms: 1) the kinetic energy of 
the nucleus; 2) the kinetic energy of the electrons; 3) the coulombic energy for repulsions 
between the nuclei; 4) the coulombic energy for the attraction between nuclei and electron 
and 5) the coulombic energy for the repulsion between electrons. The potential energy 
terms (the last three) appear exactly as they do in classical mechanics. The kinetic energy is 
expressed by the kinetic energy operator:  ̂   
  
  
  . 
Unfortunately, this expression cannot be solved exactly for more than two interacting 
particles at a time. Only single electron systems, where a single electron interacts with the 
nuclei, like the H atom or He1+, Li2+ ions, can be treated with analytically. Systems with N ≥ 3 
cannot be calculated exactly, because of the interaction terms that do not allow for a 
separation of variables [66]. In that way, it is necessary to introduce some simplifications 
and treat the systems in an approximate manner.  
 
2.3.3 The Born-Oppenheimer Approximation 
Up to now, we have been discussing many particle molecular systems entirely in the 
abstract. In fact, the wavefunctions for this kind of systems are extremely difficult to express 
because of the correlated motion of particles. In order to simplify the problem, the Born-
Oppenheimer approximation [78] may be used.  
Under physical conditions, the nuclei of molecular systems are heavier than the 
electrons and consequently they move much slower than the latter. In practice the electronic 
adaptation to a nuclear arrangement is very fast. Based on this hypothesis, it is possible to 
consider that the motion of the nucleus is not affected by the motion of electrons. Therefore, 
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the nuclear kinetic energy term can be calculated separately and the nuclear repulsion term 
can be considered as a constant for a given nuclear configuration. 
In basic terms this approximation allows the wavefunction to be broken into two distinct 
equations: 1) an electronic Hamiltonian, ̂ , with fixed nuclear positions and 2) a nuclear 
Hamiltonian, ̂ , that is easy to solve (Equation 11).  
 
 ̂        ̂     ̂  
 
 ̂     ̂    ̂      ̂       ( )                                    ̂    ̂     ̂  ( ) 
 
Equation 11. The Born-Oppenheimer approximation.  
A) Electronic contribution. B) Nuclear contribution 
 
The calculation of the electronic energies for fixed nuclei means that the nuclear kinetic 
energy term is taken to be independent of the electrons, the correlation between electrons 
and the nuclei term is eliminated and the repulsive term between nuclei becomes constant 
for a given geometry. With this approximation the electronic Hamiltonian ( ̂  ) includes only 
the second, third and fourth terms of Equation 10. 
By using the Born-Oppenheimer approximation it is possible to extend the range of 
systems for which the Schrödinger equation could be solved exactly, e.g. systems with two 
nuclei and one electron, such as the H2
+ ion. With this gain, this approximation greatly 
simplifies the calculation for any system. 
 
2.3.4 Hartree-Fock Theory 
Until now, we are able to solve analytically the energy of a system that contains two 
nuclei and a single electron, based on the Schrödinger equation and some approximations. 
With the Hartree Fock Theory, any system can be treated. The upper limit in the number 
of particles that can be used is only a computational matter. 
In the Hartree-Fock theory the correlation between electrons is discarded. This 
correlation is only included as an average effect. It is considering that each electron 
interacts with the effective field due to the nuclei and the average distribution of the other 
electrons. As mentioned before, the correlation factors between particles is the big problem 
that excludes the possibility to calculate analytically the energy of any system (with more 
than two particles). Hartree Fock calculation starts with generating a guess wavefunction 
FCUP/ICBAS 
CHAPTER 2 – Theoretical Background 
33 
 
 
with the form of a Slater determinant (represents by Equation 12). On this expression the 
numbers represents electrons and the letters represents orbitals. 
 
            
 
√  
|
  ( )   ( )     ( )
  ( )   ( )     ( )
                          
  ( )   ( )     ( )
| 
Equation 12. Slater determinant 
 
The factor 
 
√  
, is used in order to normalize the wavefunction.  
The employment of the variational principle is very important in the Hartree-Fock 
calculations. This determinant assurance that any approximate wavefunction corresponds to 
a higher energy than the real wavefunction. This insures that in order to improve the guess 
wavefunction, the energy of the system must be minimized.  
A Slater determinant is composed of spin orbitals, i.e. the orbital function multiplied by 
its electron spin. This Slater determinant and spin orbitals are responsable to assuring that 
the Pauli principle is obeyed.  
This principle states that the total wavefunction must be anti-symmetric under the 
interchange of any pair of fermions (as electrons). The interchange of two electrons is 
accomplished in a Slater determinant (by exchanging two columns), and was the 
consequence of inverting the sign of the wavefunction, according to the Pauli principle.  
The principle that no two electrons can occupy the same quantum level (the Pauli 
exclusion rule) is also obeyed by this method. To guarantee that the Pauli exclusion 
principle is not violated, when multiple electrons occupy the same spin orbital, the rows 
corresponding to that spin orbital are equal and this leads to a null wavefunction.  
Within the Hartree-Fock theory, the electronic Hamiltonian results in an operator for 
each electron, all electrons interact with a uniform electronic cloud, and the electrons are 
distributed by spin orbitals. Therefore, in order to obtain the energy, for each electron we 
have:  
 ̂     
     
Equation 13. The Hartree-Fock equations 
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where    represents the wavefunction for the spin orbital of the electron i and   
   
represent the energy associated with this spin orbital.  ̂ is the Fock operator that is 
described by the follow expression: 
 ̂    ̂   ∑ {  ̂  ( )    ̂ ( )}
 
 
Equation 14. Fock operator expression 
  
The Fock operator is a kind of Hamiltonian constructed individually for each electron. 
The   ̂  is the core Hamiltonian for one electron, which is composed by two terms: 1) the 
nuclei and electrons interactions and the kinetic energy of the electrons. The sum is over all 
other spin orbitals and it contains the operator for coulombic interactions between the 
electrons of the system  ̂  , and the exchange integral operator,  ̂ . These operators depend 
on other spinorbitals and, as a result, every Hartree-Fock equation is a function of one other. 
To solve this kind of equation a Self Consistent Field (SCF) calculation is done, with a guess 
Slater determinant and iterative optimizations, until and adequate convergence is achieved. 
Although it has been widely accepted, the Hartree-Fock theory has only analytical 
resolution for atoms. Thus, in order to enable the study of molecules it was formulated a 
new strategy that will be briefly described in the following section. 
 
2.3.5 Linear combination of atomic orbitals 
In 1951, Roothaan and Hall proposed, for molecular orbitals, a wavefunction as a linear 
combination of atomic wavefunctions. The set of these wavefunctions is called the “basis 
set”. This construction is known as linear combination of atomic orbitals (LCAO) approach. 
The combination gives rise to the molecular orbitals and consists of a predefined set of 
functions that describes atomic orbitals. The accuracy of the results depends on the number 
of basis functions used to describe the orbitals. It is important to say that the greater number 
of basis functions, the greater the computer time required. Therefore, it is necessary to get a 
balance and a compromise between the number of basis functions and the computating 
time.  
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2.4 Density Functional Theory 
As seen before, the Schrödinger equation is exact, but impossible to solve for most 
relevant systems. The Density Functional Theory (DFT) is another set of methods used to 
elucidate the chemical and physical properties of a system that has appeared during the last 
decades as a powerful methodology. It introduces a different approach based on the 
calculation of the total electronic energy and electronic density distribution, without needing 
to guess the full N-electrons wavefunction as done in the previous method.  
This method was introduced by Thomas and Fermi in 1927 [79, 80] and it is based on 
the principle that the energy of an electronic system can be defined in terms of its electron 
density, ρ. When a system has n electrons, ρ(r), represents the total electron density at a 
point of space r. The DFT formalism shows that the electronic energy E, is regarded as a 
functional of the electron density E[ρ]. It means that to a given function ρ(r), corresponds a 
single energy. The main advantage of a DFT method is that it depends only on three 
coordinates, independently of the number of electrons that constitutes the system, contrarily 
to the wavefunction calculated in the previous methods  that depend on the three 
coordinates of each electron and one more if the spin is included (4n coordinates, where n is 
the number of particles) [68, 81].  
 
2.4.1 The Hohenberg-Kohn Theorem 
The DFT methodology is based on the Hohenberg-Kohn theorem [82]. This theorem 
was published in the 1960s and it affirms that in a non-degenerated system, the ground-
state energy is uniquely defined by its electron density. In DFT the energy functional is 
written as a sum of terms as it is portrayed in equation 15: 
 
 [ (  )]   ∫     ( 
 ) (   )    [ (  )] 
Equation 15. Energy functional equation (DFT) 
  
The first term is related to the electrons with an external potential (     ( 
 )) and usually 
representing the Couloumb interactions with the nuclei. The second term is the sum of the 
kinetic energy of the electrons and the electron correlation interaction, the correlation 
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energy. The main problem with this theorem is that the function  [ (  )] is not described, it 
is unknown.  
 
2.5.2 The Konh-Sham Theorem 
Fortunately, in 1965, Konh and Sham [83], suggested a formalism that is in the 
foundation of the current application of the DFT methodology. Following this formalism the 
 [ (  )] can be approximated as a sum of three terms and simplified as: 
 [ (  )]     [ ( 
 )]    [ ( 
 )]      [ ( 
 )] 
Equation 16. Konh and Sham formalism 
 
where    [ ( 
 )]  is the kinetic energy of non-interacting electrons,   [ ( 
 )] is the 
electron-electron Coulombic energy, and    [ ( 
 )] accounts for the contribution from 
exchange and correlation interactions. 
As in the Hartree-Fock theory, to solve Hohenberg-Konh and Konh-Sham equations it is 
necessary to use a self-consistent approach. This process allows the Kohn and Sham 
equations to be solved, yielding an initial set of Kohn-Sham orbitals. This set of orbitals is 
then used to calculate an improvement of the density and the process is repeated until 
exchange-correlation energy have satisfied a certain convergence criteria, or, in other 
words, iterative steps, involving a variational  process, necessary in order to describe the 
    term.  
In DFT, it is a common procedure to divide the exchange-correlation energy in two 
separate terms: 
   ( )    ( )      ( ) 
Equation 17. Exchange-correlation energy  
 
where the   ( ) is the exchange functional associated with the interactions between 
electrons of the same spin and   ( ) is the functional of correlation between all electrons of 
the system. 
The only approximation that needs to be done in the DFT methodology is due to the 
exchange correlation functional. The Local Density Approximation (LDA) functionals 
constitute the simplest approach to represent this exchange. It assumes that the exchange 
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correlation energy, at a point in space, is a function of the electron density at that point only, 
and can be given by the density of electrons in a homogeneous free electron gas. In that 
way, an electron feels the electron density produced by the remaining electrons as if the 
density was the same in each part of the system. However, for systems that present 
changes in electronic density in space, as is the case of biological molecules, the results 
from this approximation are unsatisfactory.  
In order to improve the previous method, it is necessary to consider a non-uniform gas. 
In this case, the exchange and correlation functionals depend not only on the electronic 
density, but also on the derivatives of the density, and take into account the spatial varying 
density ρ(r). This approximation is known as the Generalized Gradient corrected 
Approximation (GGA).  A new class of functional based on GGA was developed and they 
are termed meta-GGA (M-GGA) methods. They depend explicitly on higher order density 
gradients or on the kinetic energy density as well, which involves derivatives of the occupied 
Kohn-Sham orbitals. Another different approach is the hybrid density functional (H-GGA). 
This method combines the exchange correlation of the GGA method with inclusion of a 
percentage of Hartree-Fock exchange. Some of the H-GGA also include constants that are 
calculated by mathematical adjustments through experimental results. An example of an H-
GAA functional is the B3LYP, probably the most popular density functional used in 
computational chemistry, and also in the present work. Hybrid meta-GGA functionals (HM-
GGA) represent a new class of density functionals. They are similar to the M-GGA 
functionals but they depend on the Hartree-Fock exchange, the electron density and its 
gradient, as well as on the kinetic energy density. These methods show an improvement 
over the previous formalisms, predominantly in the calculation of barriers heights and 
atomization energies. To conclude, the sequence of accuracy for density functionals is the 
following (from less to the most accurate): LDA<GGA<M-GGA<HM-GGA<Exact functional. 
However, it is important to say that from system to system, or from property to property, the 
performance of each functional can vary.  
It is also important to refer again that the main advantage of the DFT methodology is the 
low computational cost and the inclusion of correlation effects, when compared with the 
Hartree-Fock methodology. The DFT methods can be applied to systems with few hundreds 
atoms and they are advantageous in relation to the methods presented previously.  
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2.5 Basis set 
A basis set is a set of mathematical functions that are used to represent atomic orbitals 
in a quantum mechanical calculation. The larger the basis set, the fewer constraints are 
attributed to electrons and more accurate are the results. A complete basis set permits an 
optimal description of the electron probability density. However, in practice, a description of 
a complete basis set is impossible because it would involve an infinite number of functions. 
However, by finding an adequate set of basis functions, we can get good results. The 
mathematical functions used to mimic the atomic orbitals can be divided into several types 
and the most commonly used are the Slater type orbitals and the Gaussian type orbitals, 
which will be briefly described in this section. 
 
2.5.1 Slater type orbitals 
The Slater type orbitals (STO) describe the electron density around an atom. They have 
an exponential dependence on the distance of the electron to the nucleus that reflects the 
behavior of orbitals in the hydrogen atom.  
The exponential dependence assures a simple convergence with the increase in the 
number of functions. However, the calculation of three or four centers integrals is not 
possible analytically. Therefore, the STO are particularly useful in mono or diatomic 
systems.  
 
2.5.2 Gaussian type orbitals 
In turn, in Gaussian-type orbitals (GTO), the most used type of basis set, the bi-
electronic integrals are possible to calculate analytically even when the basis functions are 
centered in more than 2 atoms. 
Unfortunately, with regards to the electron density, they are not able to describe it as 
accurately as STOs do. This happens specially when the distance from an electron to the 
core increases or decreases very much. Although exponential functions are a better fit to 
describe the electronic density, the GTOs are preferable compared to the STOs, because 
the first use simplified functions that reduce the computational cost. The GTOs can be 
improved by the use of a linear combination of Gaussian functions (called a contracted basis 
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set-CGTO). These Gaussian functions are called primitives (PGTOS) and have fixed 
coefficients. These functions improve the description of the atomic orbitals near the core. 
Moreover, as the electrons closer to the core have small chemical importance, this is a good 
approximation and it does not compromise the final results.  
To improve the basis set described before, named “minimal basis sets” as each electron 
is described by a single CGTO, the split valence basis sets are used. They have a different 
scheme for core electrons and for valence electrons. The first ones are treated with a single 
contracted basis with n Gaussian primitives and the second ones are treated with two or 
three basis. The split valence basis were created by Pople reference and their nomenclature 
is represented by: 
       
where   represents the number of PGTO used for the core orbitals and    , represent 
the basis used to treat the valence part and their division. The   indicates that the basis 
used for describing the system were the Gaussian type orbitals. In this work, as we will see 
later, the 6-31G basis set was used. It is a double zeta basis set (two basis are used to 
describe the valence electrons) and it is one of the more used basis sets. In this case, 6 
GTO primitives are included in the contracted core orbitals and 2 basis are used for the 
valence electrons. The more internals orbitals are described by 3 primitive Gaussian 
functions and the external ones are described by 1 primitive Gaussian function.  
Despite the advantages, these basis sets have the disadvantage of being inflexible or, 
in other words, they do not change their shape with the molecular environment. This 
happens because this type of basis set does not describe orbital deformation when they are 
in a field created by nearby atoms. However, other methods have been applied in an 
attempt to provide greater flexibility to the wavefunction. The problem is that the s and p 
functions centered on the atoms do not provide sufficient mathematical flexibility to describe, 
in an adequate way, the wavefunction for different geometries.  
To include flexibility in the Pople basis set there are two types of functions that can be 
added, the polarization functions and the diffuse functions. The first are almost always 
added in the form of basis functions corresponding to a higher angular momentum quantum 
number than the valence orbitals. This kind of basis sets are denoted by, (for example, for 
the case of 6-31G) 6-31G** or 6-31G(d,p). The first asterisk, or d, concerns heavy atoms 
which have d functions that polarize p functions. The second asterisk, or p, includes 
hydrogen atoms with s valence electrons that are polarized by p functions. It is important to 
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say that the 6-31G(d) is the most widely basis set used because it guarantes a good 
compromise between computational cost and accuracy. In this work this basis set was used 
in all optimization calculations. 
The other kind of functions, the diffuse functions, are important to improve the 
description of electronic densities that are spatially diffused and far from the nuclei. When a 
basis set does not have a good flexibility to allow a weakly bound electron to localize far 
from the remaining density, significant errors in energies and other molecular properties can 
occur. Diffuse functions are useful in the case of anions, highly excited electronic states and 
large atoms that tend to have more diffuse electronic density than the others. The presence 
of diffuse functions is indicated by a “+” in the basis set name. If there are two plus signals in 
the basis set, the first one corresponds to the heavy atoms and the second one to the 
hydrogen atoms. 
The choice of a correct basis set is an essential step in a calculation. 
 
2.6 Hybrid QM/MM methods 
We have seen in the previous section that it is possible to study chemical reactions from 
different perspectives.  
For reasons of efficiency, the representation of large systems is most typically carried 
out at the MM level. However the molecular MM force fields, described before, are not 
sufficiently flexible to describe processes in which chemical bonds are broken or formed. To 
adequately describe  such processes, QM methods are required [70]. Nevertheless, there 
are cases in which the systems are very large to treat with QM methods. To study enzymatic 
catalytic reactions it is important to include the presence of the enzyme surrounding. The 
smallest enzymes have thousands of atoms and therefore it is impossible to study this kind 
of systems only with QM methods.  
It is known that the region of the enzymatic space in which significant changes in 
electronic structure occur, the active site, is relatively small compared to the size of the 
whole molecular system and, thus it can be treated with QM methods. The remainder of the 
enzyme may be important to maintain its structure and folding that are crucial for its activity, 
but it has small influence on the chemical reaction that takes place in the catalytic active 
site.  In that way, from a modelling perspective, we may regard the situation within a limited 
FCUP/ICBAS 
CHAPTER 2 – Theoretical Background 
41 
 
 
region, in which we should make use of quantum mechanics to accurately describe the 
electronic structure. In the surrounding region, the explicit representation of the whole 
system is important, but the level of model applied can be reduced in complexity. These 
methods, with a mixture of two or more theoretical levels are called hybrid methods. 
In QM/MM the level applied to the outer system is MM and in that way, the complete 
energy for the system must be some kind of hybrid of QM and MM methodologies:  
 
                           
Equation 18. Hybrid QM/MM energy 
 
where EQM accounts for full internal interaction energy of all quantum mechanical 
particles with one other, EMM accounts for full internal interaction energy of all classical 
particles with one other and, finally, the EQM/MM accounts for all interactions between a 
quantum mechanical particle and a classical particle. Hybrid methods allow the combination 
of two or more computational techniques in one calculation and therefore it makes it 
possible to investigate large systems.   
An important aspect to take into account when using hybrid methods is the division of 
the system. The partitioning of the system must involve the separation of covalently bonded 
atoms into different levels of theory. The way the system is “cut” must be made with special 
attention, because an inadequate choice of the atoms included in the QM or MM regions 
can lead to incorrect descriptions of the study system.  
  
 2.6.1 The ONIOM method 
There are different QM/MM methods in which the division of the study system and the 
procedure for the energy calculation is different between them. In this work the QM/MM 
methodology used is called ONIOM method. 
ONIOM (our own N-layer integrated molecular orbital molecular mechanics) [84-87] 
scheme can combine any number of molecular orbital methods, as well as molecular 
mechanics methods. In a two layer ONIOM calculation, the total energy of the system is 
obtained from three independent calculations: 
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Figure 6. Representation of the ONIOM two-layer method 
                                                 
Equation 19. ONIOM total energy 
 
The real system contains all the atoms and is calculated only at the MM level. The 
model system contains the part of the system that is treated at the QM level (high layer). 
Both QM and MM calculations need to be carried out for the model system. The schematic 
representation of the ONIOM model is shown in Fig.2.3. When there are bonded interactions 
between the two regions (QM and MM), the model system includes link atoms (in this case, 
hydrogen atoms) to saturate the open valence of the QM atom, as explained later [84]. 
A technical issue needs to be taken into account when we are studying chemical 
reactivity. When bond breaking and forming is part of the process in the QM region, it is 
safest to have the MM region at least three bonds away from the chemical process to avoid 
the cancelation problem.  However, depending on the exact parameters involved in the MM 
terms in the border region there are instances where one or two bond separations are 
sufficient.  
In the QM/MM methods there are two choices for dealing with the electrostatic 
interactions between the QM layer and the MM layer. The first, mechanical embedding 
treats the cross region electrostatic interactions at the MM level. The second, electrostatic 
embedding incorporates the cross region electrostatic interactions in the QM Hamiltonian.  
The next subsection will give a brief explanation of these representations. 
 
 
 
 
 
 
 
 
 
The system is divided in two layers. The High layer is treated with an accurate method, QM, and is the region where the 
catalytic reaction occurs. The remain system is treated with MM. 
 
FCUP/ICBAS 
CHAPTER 2 – Theoretical Background 
43 
 
 
2.6.1.1 Mechanical embedding scheme   
In the mechanical embedding scheme all interactions between the two subsystems are 
handled at the force field level. Chemical bonds between QM and MM atoms are modeled 
by harmonic potentials, as well as the angles that are defined by one QM atom and two MM 
atoms, while dihedral torsions involving at most two QM atoms are commonly modeled by a 
periodic potential function. Non-bonded interactions (between atoms separated by three or 
more atoms) are also modeled by force field terms: the van der Waals and the electrostatic 
interactions. 
In the simplest implementation of mechanical embedding scheme, the electronic 
wavefunction is evaluated for an isolated QM subsystem. Therefore, the MM environment 
cannot induce polarization in the QM region. For calculating the electrostatic interactions 
between the subsystems, one can either use a fixed set of charges for the QM region, or re-
compute the partial charges on the QM atoms at every integration step if we are running a 
MD simulation. In geometry optimizations an update of charges at the end of each 
optimization is required to load QM charges for the next step.  
Lennard-Jones parameters are normally not updated. Because of that, problems may 
arise if some changes occur in the chemical character of the atoms in the QM region, as 
changes in hybridization state of the atoms. However, since Lennard-Jones potential is a 
relatively short-ranged function, the error, introduced by keeping the same parameters 
throughout the calculations, is most likely not very large [88]. 
 
2.6.1.2 Electrostatic embedding scheme   
To improve mechanical embedding, a new scheme that includes polarization effects in 
the boundary interactions was developed, the electrostatic embedding scheme. In this 
scheme, electrostatic interactions between the two subsystems are handled during the 
calculation of the electronic wavefunction. The MM atoms can polarize the electrons in the 
QM subsystem. However, the atomic charges of the MM atoms have been parameterized to 
provide the realistic description of an MM system, rather than a physically correct charge 
distribution. The main doubt is if this strategy is realistic or not. In reality, the interaction 
between the systems, is not only due to the electrostatics between charged atoms, but also 
due to the polarization, exchange, charge transfer, dispersion and Pauli repulsion. In force 
 44 FCUP/ICBAS 
Elucidating the catalytic mechanism of human renin with hybrid QM/MM studies   
  
 
  
fields, only the combination of atomic charges and Lennard-Jones parameters provides a 
reasonable description of all these effects taken together. In other words, not only the MM 
charges but also the Lennard-Jones parameters would need to be parameterized for use in 
the electrostatic embedding scheme.  
A further problem is the risk of over polarization near the boundary. The point charges 
on the MM side of the interface may attract or repel the electrons too strongly, leading to 
electron density spilling out into the MM region. This over polarization could be serious if a 
large basis set, with polarization and diffuse functions, or plane waves are used in the QM 
calculations. 
 
2.6.1.3 QM/MM boundary and link atoms 
If the QM and MM subsystems are connected by chemical bonds, some care has to be 
taken. A straightforward cut through the QM/MM bond creates one or more unpaired 
electrons in the QM subsystem that, in reality, are paired with electrons belonging to the 
atom on the MM side.  
In cases where there are non-bonding interactions between QM and MM atoms, there 
are no problems. In some other situations, it is necessary to split a molecule between QM 
and MM region, which means that there will be covalent bonds between the two regions. 
These bonds must be treated in a different way because the presence of unpaired electrons 
at the boundary of the QM region can dramatically change the electronic structure of the QM 
system. The most widely method used in application is the simple link atom method.  
Link atoms are the easy solutions to treat the boundary between QM and MM regions. 
The strategy of using link atoms consists in introducing atoms at an appropriate position 
along the bond vector between the QM and MM atoms. Hydrogen is the most often atom 
used as link atom, but methyl groups and fluoride atoms can also be applied. The link atoms 
are present only in the QM calculation and they are invisible to the atoms in the MM region. 
Each link atom introduces three additional degrees of freedom to the system. 
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CHAPTER 3 
COMPUTATIONAL METHODOLOGY  
LINE OF WORK 
 
 
3.1 Introductory note  
As we have seen until now, the study of the catalytic mechanism of an enzymatic 
reaction is very important for future drug design. In the study of human renin, the knowledge 
of the catalytic mechanism with atomistic detail has an essential and determinant role in the 
development of new and more efficient antihypertensive drugs. 
The starting point of any theoretical enzymatic study is a good tree-dimensional 
structure of the system. It is essential to identify the minimal system which mimics 
realistically the biological study system because a successful computational study greatly 
depends on the initial structure. The experimental data available on the literature are 
indispensable for a computational enzymatic study.  These studies can offer structural 
information of enzymes and their substrates, obtained by protein crystallography and NMR 
spectroscopy techniques, which are crucial for starting this kind of studies.  
The Protein Data Bank (PDB) [89] is the best known and the more complete archive of 
structural data of biological macromolecules with three-dimensional structures. Sometimes, 
when initiating a study there several crystallographic structures of the same protein. In these 
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cases, it is necessary to pick the “best” structure and the most usual selection criteria is the 
crystallographic resolution, which indicates how well defines the crystal structure is, the 
presence of ligands and how complete the structure is. The selection of the initial structure 
of a system must be made with special attention in order to guarantee the success of the 
study. 
 
3.2 Preparation of the system  
 First of all, this work starts with a search in PDB database by “human renin”. After the 
analysis of all published structures, the initial structure was taken from PDB 2REN, which 
contains the crystallographic structure of free human recombinant renin at 2.5 Å resolution 
[42]. The selection was based on the resolution of the structure and how complete the 
structure is. With the structure of this enzyme three different models were built. 
 
3.2.1 Ren:Angdodecapetide:W1 model  
In the first model the substrate was modelled from the N-terminal peptide tail residues 
(Val3 – Asn14) from human angiotensinogen, from PDB 2X0B, at 4.4 Å resolution [90]. 
Despite the low resolution of this structure, part of it was used to modulate subtract because 
it was the only published crystal structure containing human angiotensinogen (Figure 7A) 
The catalytic water molecule was modelled in the active site of the enzyme.  
 
3.2.2 Ren:Angdodecapetide:W1:W2 model 
The second model was similar to the previous one, but with an extra structural water 
molecule, establishing hydrogen bonds between the Tyr83 and Ser41 residues, as shown in 
Figure 7B. This water molecule has been described as important for the catalytic 
mechanism of aspartic proteases. With these two templates we will evaluate the role of it in 
the catalytic mechanism of human renin. 
 
3.2.3 Ren:Angmutated model 
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A third system was modelled using the optimized native structure. In this substrate, the 
Leu10 residue was replaced by a Phe residue (Figure 7C). This mutation was previously 
associated with preeclampsia, a common hypertensive disorder of pregnancy [91] .  
The substrates were modulated in the renin cleft and then we align and superimposed 
the modeled system with the renin-angiotensinogen structure from PDB 2X0B.  
The hydrogen atoms were added with Amber software X-leap [92] , considering the 
residues in their physiological protonation states. The exception was the catalytic Asp38 
(proton donor residue) which was protonated according with previous experimental results 
and consistent with the proposed mechanism for aspartic proteases [4, 93]. Also with X-
leap, eight counter-ions (Na+) were added to neutralize the negative charge of the system. 
An explicit solvation model was used, with pre-equilibrated TIP3P water molecules in a 
truncated octahedral box with a minimum distance of 12 Å between the protein atoms and 
the box faces. The three systems had approximately 52650 atoms and the final models are 
similar to the system represented in Figure 7 and Figure 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The central image represents renin and the ramifications represent the slight variations of the different models used in this 
Catalytic Asp residues, Leu/Phe and Val residues of the scissile bond, and the catalytic (W1) and structural (W2) water 
molecules are represented in ball and sticks. (A) Active site representation of Ren:Angdodecapetide:W1 model; (B) Active site 
representation of Ren:Angdodecapetide:W1:W2 model, where the second water molecule established H-bonds with Tyr83 and 
Ser41. (C) Active site representation of Ren:AngMutated model, where the Leu substrate residue was replaced by a Phe residue. 
Asp226 
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W1 
B
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Figure 7. Representation of the differ nt mod l  used in the present work. 
 48 FCUP/ICBAS 
Elucidating the catalytic mechanism of human renin with hybrid QM/MM studies   
  
 
  
The geometry of the systems was minimized to release the bad contacts in the 
crystallography protein. The minimization was proceeding in two stages. In a first stage the 
protein is fixed and the position of the water molecules and counter ions was minimized. 
After, in a second stage, the full system was minimized.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The water molecules are represented in the box of 12Å around the protein. 
 
 
3.3 Molecular dynamics simulations 
 In order to understand the behavior of the system in study, molecular dynamics 
simulations were performed. This computational method provides detailed information on 
the fluctuations and conformational changes of the system along time. The MD simulations 
were performed with Sander module implemented in AMBER09 software [94], using the 
Amber 2003 force field (parm03) [95]. 
After the minimizations a two-step MD simulation was run. First, an equilibration stage 
was performed using constant volume (NVT canonical ensemble) and considering periodic 
boundaries conditions. During this simulation the temperature was equilibrated using the 
Langevin temperature equilibration scheme, with an initial temperature of 0 K and final 
temperature of 310.15 K, during 200 ps. After, 6 ns of MD were run with constant pressure 
(NPT isobaric-isothermal ensemble) in the production stage. A collision frequency of 1 ps-1 
was used to control the temperature. The SHAKE algorithm [96] was used in order to 
Figure 8. Representation of the system used in Molecular Dynamics Simulation. 
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consider the bond lengths involving hydrogen bonds and equations of motion were 
integrated with a 2 fs time-step. A 10 Å cutoff was used to truncate the no bonded 
interactions. The temperature was regulated with Langevin thermostat [97] to be maintained 
at 310.15 K during all the simulation. The results of the MD simulations were analyzed with 
PTRAJ module, which is included in the Amber package. 
 
3.4 QM/MM calculations 
3.4.1 Determination of the potential energy surface  
The QM/MM calculations used to determine the potential energy surface (PES) along 
the catalytic pathway were run using the Gaussian 09 software [94]. The initial structures 
were obtained from the last minimization step before the MD simulations. In these models 
we have include the complex enzyme-substrate and the solvent water molecules in a radius 
of 5 Å around the complex. The total system was composed by 8204 atoms. 
The ONIOM subtractive scheme [85], implemented in Gaussian 09, package was used 
to explore the PES energy along the catalytic reaction and we divided our system into two 
layers, a high level layer and a low level layer.  
For the study of enzymatic reaction using QM/MM methods it is essential that the atoms 
included in either level are correctly selected. In the geometry optimizations, the high level 
layer included part of Leu10/Phe10 and Val11 residues of substrate, part of the lateral 
chains of catalytic Asp (Asp 38 and Asp 226) and the catalytic water molecule, with a total of 
33 atoms Figure 9B. 
The selection of the residues included in high level layer was based on previous 
experimental and theoretical studies, and specially in a previous study in the catalytic 
mechanism of mouse renin, which was developed by our group [4]. This high layer was 
treated with DFT with B3LYP functional and 6-31G(d) basis set [98, 99]. The remaining 
system was treating at MM level with parm99 force field (Amber). The hydrogen atoms were 
used as link atoms to simulate bonds and satisfy the valences of covalently bonded atoms 
across the QM/MM boundary. Residues with at least one atom within 20 Å around any QM 
atom were kept free, while the remaining part, beyond the 20 Å radius, were kept frozen. 
The described system was used in the initial optimization and the optimized structure 
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presented small differences when compared to the crystallographic prepared system. The 
same protocol was used for the three different models. 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) Representation of all system which includes the whole enzyme, the substrate (angiotensinogen dodecapeptide tail) and a 
shell of water molecules. The enzyme is represented with cartoon scheme. The system was divided in two layers: a high layer 
treated at QM level and a small layer treated with MM level. The high layer was represented with a large size in (B). The 33 
atoms treated with QM level (DFT) are represented by balls and sticks. 
 
A correct description of a TS structure is essential in understanding the progress from 
reactant to product as it is also important in developing of new drugs.  Transition states were 
considering as the higher energy structures, which are described as good approximations to 
these states. The most reliable way of encountering a TS in a reaction profile involves the 
use of a linear transit scan. This consists in establishing the energy of several structures 
along a reaction coordinate, which will produce an energy curve where it is possible to 
identify the structure with highest energy. Therefore, we performed a linear transit scan 
along the reaction coordinate for each reaction step with increments of 0.10Å or 0.05Å to 
locate all the stationary points. To initiate the study of the chemical reaction the optimized 
structure was used as the initial structure.  
Figure 9. Representation of the system used in QM/MM calculations 
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The interaction between the two layers was described with mechanical embedding 
scheme, at the MM level. The atomic point charges for high layer atoms were recalculated   
in each step of the scan. These atomic point charges were obtained during a single point 
calculation using the Merz-Singh-Kollman scheme [100]. These calculations used the RESP 
(Restrained Electrostatic Potencial) charge fitting program [101, 102]. 
In the stationary points, single-point (SP) energy calculations were performed using the 
electrostatic embedding scheme and a more complex basis set (6-311++G(2d,2p)) [103].  
  
3.4.2 Increase of the QM region 
Afterwards, the high layer region (treated at QM level) was progressively increased 
(only for the Ren:Angdodecapetide:W1 model) and new SP energy calculations, with B3LYP/6-
31G(d) and B3LYP/6-311++G(2d,2p) levels, were performed. The increase of the QM model 
aimed to include the influence caused by residues around the active site, seeking to improve 
the energies of the catalytic reaction. This progressive increase was made in spherical 
shells, with a spherical radial increase centered on the catalytic water molecule. The new 
models are described below: 
 
1) In the first new model, lateral chains of Leu10 and Val11 residues, from substrate, 
were added to the QM region. In Figure 10 the atoms that were added are coloured green. 
This system has 55 atoms in the high layer. 
 
2) The second new model included, in QM region, the same residues present in 
previous models and also Ser38, and Tyr83 from enzyme and His9 from substrate. In the 
Figure 10 the new QM residues are coloured light blue. This system has 100 atoms in the 
high layer. 
 
3) The third new model includes the same residues present in previous models and 
also Gly40, Ser84, Gly217 and Ala218. In Figure 10 the residues included in the new QM 
region are represented by the violet atoms. This system has 135 atoms in the high layer. 
 
4) In the fourth new model Thr36, Val121, Leu213, Val214 and Thr216 residues and the 
complete chains of the catalytic Asp were added to the previous QM region. In Figure 10 the 
new QM residues are represented by the pink atoms. This system has 210 atoms in high the 
layer. 
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5) Finally, in the fifth and large model Leu75, part of Arg76, Gly80, Val122, Thrt79, 
Thr289, Ile330 residues were added to the QM region. In Figure 10 the new QM residues 
are coloured orange. This system has 322 atoms in the high layer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The different colors represent the residues that were added to the initial model. The initial QM region is represented by balls 
and sticks, and the atoms added to the first new QM region are represented in green.  For the second model the light blue 
residues were added. Then the violet residues were also included in QM region. For the next model the pink residues were 
added and finally for the biggest model the orange residues were also included in the calculations. 
 
Figure 10. Representation of the atoms included in the different QM regions. 
FCUP/ICBAS 
CHAPTER 4 – Results and Discussion 
53 
 
 
 
CHAPTER 4  
 RESULTS AND DISCUSSION 
 
 
 
4.1 Introductory note   
 In the present work, we tried to understand the atomistic details of angiotensinogen 
hydrolysis catalysed by human renin. First, the results from MD simulations will be 
presented, in order to understand the dynamics of the system over time. Afterwards, the 
structures along the reaction mechanism and the hydrolysis energetic pathways will be 
discussed. Also in this chapter the role of a structural water molecule in the substrate 
cleavage and the difference between the renin reaction with wild type and mutated 
substrates will be evaluated. Finally, the human renin catalytic mechanism, which was 
studied in this work, will be compared to mouse one, which was recently published by our 
group [4].  
 
4.2 MD simulation  
 As has been previously mentioned, in MD simulations three different systems were 
studied. The first one contains the angiotensinogen terminal dodecapetide, the second one 
a structural water molecule and angiotensinogen terminal dodecapeptide, and the last one 
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the Leu10Phe mutated substrate. After 200ps of equilibration, the simulations were run for 
6ns and the results were analysed using PTRAJ tool, as previously mentioned.  
 
4.2.1 Root Mean Square Deviation 
The first analyzed parameter was the Root Mean Square Deviation (RMSd) that is a 
measure of the differences between the positions of specified sets of atoms. This measure 
is normally used to compare different conformations of the system under study during the 
time course of a MD simulation.  
The RMSd values along the MD simulation performed on the first system are 
represented on Figure 11. It is possible to see that renin, represented by the blue line, does 
not change much its conformation during the simulation. After the equilibration simulation, 
renin does not vary much then 1Å. RMSd values for renin:dodecapeptide complex have 
large variations than the values obtained for the unbounded enzyme. At the end of MD 
simulation its position still oscillates about 2.5Å, however the complex seems to be 
stabilized.  
 
 
 
 
 
 
 
 
 
 
 
 
Renin RMSd is represented in blue and Renin:dodecapetide RMSd is represented in green. Both values are stabilized at the 
end of MD simulation. 
 
4.2.2 Root Mean Square Fluctuation 
Then, the root mean square fluctuations (RMSf) was also analysed. The RMSf is a 
measure of deviation between the position of a particle (i.e. residue or atom) and a 
reference position (time-avaraged position). 
 
 
 
 
Figure 11. Renin and Renin:dodecapeptide RMSd along the MD simulation 
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A) RMSf of renin resides. The dark blue line represents the protein region with large fluctuations. The Ang226 and resides 
around this catalytic resid are included in this region. B) RMSf of angiotensinogen dodecapeptide by residue. 
 
 The analysis of renin fluctuation (Figure 12A), during the MD simulation, shows that 
residues between the positions 220 and 260 (in complex pdb numeration) have the large 
fluctuation. These residues correspond to an external region of the protein and, probably 
because of it, they are more flexible. The residues that corresponds to the catalytic Asp38 
and Asp226 (35 and 215 in complex pdb numeration) have also large fluctuations during the 
MD simulation. 
 The analysis of angiotensinogen fluctuation by atom shows that the first 2 residues (Tyr 
and Val) are the more flexible ones. They correspond to the first residues of 
angiotensinogen dodecapeptide tail. This residues have large and flexible lateral chains and 
because of it is expectable a large fluctuation.  
 
4.2.3 Active site interactions 
   
 The length of interactions between catalytic atoms was also analysed during the MD 
simulation. This analysis is shown in Figure 13. The analysis of this figure shows some 
differences between the distances of represented atoms along the MD simulation. The major 
differences are visible after the 2ns of production, especially in the interactions between the 
water molecule and the catalytic residues. 
 
 
 
 
 
 
Figure 12. RMSf of Renin and Angiotensinogen residues along the MD simulation. 
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Seven different interactions were represented. Brown line represents the interaction between catalytic water molecule and Leu 
residue of the scissile bond. Pink line represents the interaction between the catalytic water molecule and Asp38. Green line 
and violet line represent the interaction between the catalytic water molecule and oxygen atoms of Asp226. Yellow line 
represents the interaction between the Leu residue and Asp38. Finally the blue charts (light and dark) represents the 
interaction between Asp38 and Asp226. The distances for the other two systems were not represented because their 
behaviour was very similar to the presented one. 
 
The distance between the water molecule atoms and some catalytic residues, at the 
end of the simulation, is approximately 50Å (not represented), which indicates that the 
interactions between these atoms completely cease after some time of simulation. During 
the course of MD simulation, it is also visible an approximation of the catalytic aspartates.  
 The visualization of the catalytic site residues and catalytic water molecule positions, 
during the dynamics, helps to understand the changes that happened throughout the 
simulation. Figure 14A shows the catalytic site of renin:angiotensinogen dodecapeptide 
complex before the MD simulation, and the Figure 14B represents the same system at the 
end of simulation. The starting structures for MD simulations were obtained by the X-ray 
crystallographic files of renin and angiotensinogen, followed by a superimposition with 2X0B 
structure, as mentioned before. At this point, catalytic Asp residues were in a coplanar 
position. The H-bond interaction between Asp35 proton and scissile bond carbonyl oxygen 
had a length of 1.74Å, and the catalytic water molecule was directed towards Asp226. 
 
 
  
Figure 13. Representation of the main active site interactions throughout MD simulation. 
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(A) Before the MD simulation the catalytic Asp residues are in a planar position and they established H-bonds with the scissile 
bond carbonyl oxygen or with the catalytic water molecule. (B) After 2ns and until the MD simulation’s end the water molecule 
moves away from the active center and the catalytic Asp residues remain directed to one another. 
 
During the simulation, the water molecule gets apart from catalytic site and the Asp 
residues gets directed to each other. The observed geometries explain the changes in 
previous analyzed distances (Figure 13). This latter geometry is unfavorable to the 
occurrence of the catalytic reaction. The behavior of the other systems (with a second water 
molecule or with mutated substrate) was quite similar to the previously presented.  
The catalytic water molecule was modeled on the active site of renin and, because of 
this, its position can vary more than the expectable, which may explain the diffusion of this 
molecule. This behavior has also been observed for other aspartic proteases. 
The results obtained in the MD simulations allowed the analysis of system’s 
conformational changes over the time. It was possible to observe that the system can 
change between two main positions, one conducive to the occurrence of the catalytic 
reaction and another unreactive. In this work, the MD simulations were performed only as an 
A 
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OD1 OD1 
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Figure 14. Representation of the renin:angiotensinogen system before and after the MD simulation. 
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initial study to know the behavior of the system along the time. The MD results have not 
been used for the catalytic mechanism study, however the structures obtained along the 
simulation could be useful for future studies on catalytic mechanism with different starting 
structures.  
 
4.3 The catalytic mechanism of human renin 
 
4.3.1 The Reactants structure 
 The model using the 2REN and 2X0B crystallographic structures, which was built in the 
beginning of this work (Ren:Angdodecapetide:W1 model) was optimized freely using to the 
default convergence criteria using the ONIOM method. 
 In the optimized structure, for the initial reactants, a water molecule (W1) interacts by 
hydrogen bonds with Asp38 (protonated) and Asp226 (unprotonated) residues of the 
catalytic site. The protonation of the catalytic aspartates is based on previous studies, as 
referred before. The active site of aspartic proteases is mono-protonated however it can be 
organized in two different forms. In the more stable form, the proton is allocated between the 
catalytic aspartate residues dyad, and it is shared in a hydrogen bond with both residues, 
which have a coplanar and symmetric conformation. However this structure is not as 
suitable for the catalysis as the second one. In this second form the Asp38 is protonated and 
it is H-bonded to the carbonyl oxygen of the substrate scissile bond [93]. In this work, we 
studied the second form and we used angiotensinogen tail (dodecapeptide) as substrate, 
which occupied the renin binding cleft. 
 In the reactants structure, the catalytic water molecule was placed between the catalytic 
aspartate dyad (Asp38 and Asp226) and the scissile bond of the substrate (Leu10 and 
Val11). The hydrogen bonds between these residues were represented in Figure 15A and in 
Table 2 and have the following values: HW1-OAsp226 - 1.90Å and HW1-OAsp38 - 2.07Å. At this 
stage, the Asp38 carboxylic group proton is orientated to the carbonyl oxygen of Leu10 and 
they establish a hydrogen bond with a length of 1.60 Å (Figure 15A). The Ser41 hydroxyl 
group forms a hydrogen bond with the carboxyl group of the Asp38, acquiring the latter one 
a more acidic character. It is also important to mention that two glycine residues (Gly39 and 
Gly220) also stabilized the aspartate dyad in the reactants structure, mainly the negative 
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charge of Asp226. There is also an important network of hydrogen bonds between Asp38-
Ser41-Tyr80-Trp45 (data not shown). 
 
4.3.2 The first reaction step 
 As we saw before, the first step of aspartic proteases proposed mechanism involves the 
formation of a gem-diol intermediate. Therefore, to study the renin catalytic mechanism, the 
reaction coordinate adopted for the first step was the distance between the catalytic water 
oxygen and the carbonyl carbon of the scissile bond (Figure 15A). 
 In this step, the protonated aspartate residue (Asp38) acts as an acid and the 
unprotonated one (Asp226) acts as a base. The enzyme activates the catalytic water 
molecule, which performs a nucleophile attack on the carbonyl carbon of the Leu10 residue 
from the substrate, concomitantly with the donation of a proton from Asp38 to the scissile 
bond carbonyl group. The optimized TS structure is shown in Figure 15B. With a detailed 
analysis on the TS for the first catalytic step (TS1), it is possible to see that the water 
molecule comes near to the carbonyl group of the scissile bond. The distance between OW1 
and Ccarbonyl decrease from 2.77Å to 1.78Å. The proton of Asp38 comes closer to the 
carbonyl oxygen, but it is not yet transferred. The distance between these two atoms is 
1.43Å at this point. The proton remains bonded to the Asp226 oxygen with a distance of 
1.07 Å. This step does not cause great changes in the remainder system, which preserves 
its overall structure.  
 Then the structure of the first intermediate was found and, only at this stage, the proton 
from Asp38 has been completely transferred to the carbonyl carbon (bond length of 1.01Å). 
At the same time, during this step, one proton from the catalytic water molecule approaches 
to the carboxylate of negative Asp38 (bond length of 1.02Å) and a new covalent bond is 
established. This step leads to the formation of a gem-diol intermediate, in which two 
hydroxyl groups are attached to the carbon of the scissile bond and the catalytic Asp38 and 
Asp226 are negatively charged and neutral, respectively.  At this step, the hybridization of 
the carbonyl carbon changes from sp2 to sp3, as expected, and the scissile bond carbon’s 
geometry becomes tetrahedral instead of planar. In the intermediate structure the two 
hydroxyl groups are oriented to the Asp38 and they establish hydrogen interactions with 
both oxygen atoms of the carboxyl group with distances of 1.66Å and 1.64Å. 
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Although the similarities of the first intermediate with the gem-diol intermediates from 
other aspartic proteases, the TS1 from human renin is therefore different from the one 
proposed for other aspartic proteases like BACE-1 or HIV-1 proteases, in which a hydroxyl 
anion is formed at this stage [50, 93].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) Representation of the structure used as reactants. The adopted reaction coordinate are represented by the arrow between 
Leu10:C and W1:O. B) Representation of the TS1 structure. At this step the W1:O is near Leu10:C. C) Representation of the 
gem-diol INT1 structure. The main interactions between the atoms in the active site are represented in the figure. Other 
interactions are represented inTable 2. 
 
It is also important to observe the behavior of the residues around the active site. In the 
TS1 and INT1 geometries the network of hydrogen bonds between Asp38-Ser41-Tyr80-
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Figure 15. Reactants, TS1 and INT1 obtained geometries for Ren:Angdodecapeptide:W1 model. 
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Trp45 is also kept as in the reactants (data not shown). The Ser41-Asp38 H-bond is 
shortened along the reaction coordinate from 1.85Å in reagents to 1.80Å and 1.68Å in TS1 
and INT1 respectively. This residue stabilizes the carboxylate during the deprotonation of 
Asp38. 
 
4.3.3 The second reaction step 
Studies in other aspartic proteases have showed that the catalytic mechanism of this 
kind of enzymes occurs by two steps. After the formation of the gem-diol intermediate, the 
amide nitrogen is located in a better position to get the proton from Asp226, and this 
transference facilitates peptide bond cleavage. At same time the proton returns from the 
gem-diol intermediate to the Asp226.  Because of this, we started our second step reaction 
from the INT1 structure, and the reaction coordinate adopted was the distance between the 
Asp226 proton and the nitrogen of the scissile bond. Figure 16 shows the second TS (TS2) 
and the second intermediate (INT2) geometries obtained in the second mechanistic step.  
 Comparing the INT1 and TS2 geometries, some important differences are evident. The 
approach of the Val11 nitrogen to Asp226, leads to the break of the H-bond between 
Asp216 and gem-diol hydroxyl and this Asp residue change its position with a rotation of its 
lateral chain. In the TS structure the proton from Asp226 is still not completely transferred to 
the amide nitrogen (1.30Å), but in the second intermediate the complete proton transference 
occurs (Figure 16B). Along this second mechanistic step, the substrate scissile bond 
stretches to 1.57Å at TS2 geometry and 1.6Å in INT2 geometry. This last distance means 
that this bond has not been completely cleaved at this step.  
During this step, the proton transfer back from the gem-diol hydroxyl to Asp38 was also 
not observed. These results are different from previous studies on aspartic proteases in 
these two aspects. The hydrogen bond network mentioned before was conserved also in the 
TS2 and INT2 geometries. Furthermore, in the INT2 structure the catalytic aspartates have 
negative charge, the amide nitrogen has a positive charge and the products are not 
completely formed. These results are also different from previous studies on β-secretase 
that suggests a reorientation of the Ser41 and disrupt of the H-bonds established with Tyr83 
which was not observed in our results for human renin [50, 104].  
At the end of this second step, the products are not fully formed and therefore we 
performed a third reaction step that will be explained bellow. 
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The reaction coordinate adopted is represented by the blue arrow between Asp226:H and Val11:N. A) Representation of the 
TS2 geometry. B) Representation of the INT2 geometry. The main interactions between the atoms in the active site are 
represented in the figure. Other interactions are represented in Table 2. 
 
4.3.3 The third reaction step 
We have performed a third mechanistic step in order to obtain the products of 
angiotensinogen hydrolysis by human renin. At this step the distance between the proton 
from one gem-diol hydroxyl group and the oxygen from Asp38 carboxyl group was used as 
reaction coordinate. The distances between carboxyl oxygen and the two protons from gem-
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A- 2nd Transition State 
B- 2nd Intermediate 
Figure 16. TS2 and INT2 geometries obtained for Ren:Angdodecapeptide:W1 model. 
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diol (carboxyl OD1:gem-diolH1 and carboxyl OD2:gem-diolH2) was tested as reaction 
coordinates, but only the first one leads to the scissile bond cleavage. During the scan the 
structure of TS3, followed by the structure of the reaction products (P) were obtained. During 
this step one gem-diol proton was progressively transferred to carbonyl oxygen of Asp38 
and the scissile bond length increases and spontaneously breaks. The geometry of the final 
products shows a protonated catalytic dyad and two independent peptides, one with a 
charged carboxyl terminal group and another one with a neutral amine terminal (Figure 
17B). Probably the initial protonation state (with protonate Asp226) will be obtained after the 
product release from the active center.  
 
4.3.4 Summary of human renin reaction 
The results obtained by our calculations shows that the reaction catalyzed by human 
renin is based on an acid/base mechanism and it occurs through three elementary 
reactions. First, the water molecule attacks the carbonyl group of the substrate leading to 
the formation of the gem-diol intermediate. The second step is initiated by the protonation of 
the peptide nitrogen of the scissile bond, and the third and last step is characterized by the 
transfer of the gem-diol proton back to the Asp38 accompanied by the complete cleavage of 
the substrate peptide bond and the formation of the products. 
 
        
  
 64 FCUP/ICBAS 
Elucidating the catalytic mechanism of human renin with hybrid QM/MM studies   
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction coordinate adopted is represented by the arrow structure between Asp38:OD1 and Gem-diol:H1. This step leads 
to the formation of two peptides. A) Representation of the TS3 geometry. B) Representation of the P geometry. The main 
interactions between the atoms in the active site are represented figure. Other interactions are represented in Table 2. 
 
Table 2. Representation of the main interactions between the active residues and the residues around the active site 
during the reaction mechanism for Ren:Angdodecapeptide:W1 model. 
Distances/Å R TS1 INT1 TS2 INT2 TS3 P 
Active Residue 
Leu10:C-W1:O 2.77 1.78 1.45 - - - - 
Asp38:OD2-Leu10:O 1.63 1.43 1.01 - - - - 
Asp228:OD2-W1 H1 1.90 1.68 1.02 - - - - 
Leu10:C-Val11:N - - - 1.52 1.57 1.61 3.44 
Asp226:HW1 -Val11:N - - - 1.30 1.07 1.05 1.02 
HAsp38-gemdiol-Asp38 - - - - - 1.31 1.03 
HW1-gemdiol-Asp226 - - - - - 3.16 1.02 
Residues around the active site 
Tyr83:H-Ser41:O 2.79 2.46 2.60 2.16 2.23 2.34 2.51 
Ser41:H Asp38:OD2 1.85 1.80 1.68 1.72 1.73 1.75 1.80 
His9:H Asp226:OD2 1.76 1.82 2.06 2.01 1.82 1.79 1.80 
 
4.4 The role of a structural water molecule 
Water molecules are an integral part of proteins, aiding in stabilization the protein fold 
and participating in their function.  
Figure 17. TS3 and Products geometries obtained for Ren:Angdodecapeptide:W1 model. 
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Some studies showed that a structural water molecule (W2), located at the vicinity of 
the active groups, is conserved between aspartic proteases [54, 105]. These studies 
suggest that the W2 plays an essential role in formation of a network of hydrogen bounded 
residues (Asp38-Ser41-W2-Tyr83-Trp45) between the active carboxyl residues and the flap, 
which can assist the development of the catalytic reaction. In that way, in this work we 
compared the renin catalytic mechanism in the absence and presence of this water 
molecule. The mechanism with the W2 molecule will be described below. 
 
4.4.1 The Reactants structure 
Similar to the previously presented mechanism, in this new model, a catalytic water 
molecule, W1 molecule, also interacts with the Asp38 and Asp36 residues of the catalytic 
dyad. This W1 is also located between the catalytic dyad and the scissile bond of the 
substrate. The interaction between this water molecule and the residues around the active 
site is represented in Figure 18A. The distance between W1 and the oxygen of the carbonyl 
carbon, in the optimized structure, is slightly higher than that observed in the previous model 
however the remaining interactions are quite similar in both models. The protonation of the 
catalytic Asp residues was similar to the previous model, with Asp38 protonated and Asp226 
unprotonated. 
 In this new model, the W2 molecule is located between Ser41 and Tyr83 residues. It 
established a network of interactions that starts in Asp38 to the Trp45 (not represented in 
Figure 18). All other residues, those are located around the active center, also maintain the 
same interactions observed in previous presented model. 
 
4.4.2 The first reaction step 
From the optimized structure described above, the reaction coordinate adopted was, as 
in the previous model, the distance between the oxygen from the W1 molecule and the 
carbonyl carbon of the scissile bond. During the scan along the reaction coordinate the 
geometry of the TS1 geometry was founded and it is represented in Figure 18B. 
A detail analysis on this structure shows that the attack of the catalytic water molecule is 
also accompanied by simultaneous delivery of a proton from Asp38 to the oxygen of 
carbonyl group. The carbon atom of scissile bond and the oxygen atom from water molecule 
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are 1.75Å away from one another. Comparing this interaction with the same one obtained in 
the previous mechanism (1.78Å), they are quite similar. Regarding to the residues around 
the active site, they are also in very similar positions. The length of the hydrogen interaction 
established between the catalytic water molecule and the Asp38 was, at this point, 1.74Å, 
which is similar to the distance obtained in the previous mechanism (1.80Å). The interaction 
between this water molecule and the other catalytic Asp residue (Asp226) has a length of 
1.67Å, which is also close to the value obtained earlier. The interaction between the Asp38 
proton and the carbonyl oxygen was 1.39Å which is also similar to the 1.45Å observed in the 
previous mechanism. The slight differences between the geometry of the first TS for these 
two mechanisms are probably due to the presence of the structural water molecule. 
Regarding the structure of the INT1 structure (Figure 18C), it was also very similar to 
the structure described for the previous mechanism. The gem-diol hydroxyl groups 
established hydrogen interactions with the carboxyl oxygen atoms of the Asp38 (1.65Å and 
1.63Å compared to 1.66Å and 1.64Å from INT1 geometry obtained in the previous model). 
The interactions between the active site residues and around residues were also quite 
similar to those previously obtained. Therefore, we can conclude that in a structural view, 
the W2 molecule does not appear to affect the first step of the reaction catalyzed by human 
renin.  
 
4.4.3 The second reaction step 
As in the preceding mechanism, we start the second reaction step with the INT1 
optimized structure, and the reaction coordinate adopted was the distance between the 
Asp226 proton and amide nitrogen of the scissile bond. The structure of the TS2 (Figure 
19A) was found at a distance of 1.20Å between Asp proton and the amide nitrogen. A detail 
analysis of this structure shows that when we approach the proton to the amide nitrogen, the 
hydrogen interaction between the aspartate and gem-diol hydroxyl groups have been broken 
and the Asp226 change its position with a little rotation. The same behavior was observed in 
the previous mechanism. 
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A) Representation of the structure used as reactants. The adopted reaction coordinate are represented by the arrow between 
Leu10:C and W1:O. B) Representation of the TS1 geometry . At this step the W1:O is near Leu10:C. C) Representation of the 
gem-diol INT1 geometry. The main interactions between the atoms in the active site are represented in the figure. Other 
interactions are represented in Table 3. 
 
Also in TS2 geometry, the scissile bond stretched to 1.54Å. All the interactions between 
the active site residues are maintained during this part of the second reaction step, and they 
are similar to the interactions observed to the previous mechanism. The Ser41 residue 
interacts with Asp38 through a 1.72Å hydrogen bond, as in the previous mechanism. With 
this result, we can conclude that the presence of the structural W2 is irrelevant for the active 
site rearrange during the TS2 formation.  
The complete transfer of the Asp226 proton to the amide nitrogen only occurs in INT2, 
which is also similar to the previous presented mechanism without the structural water 
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Figure 18. Reactants, TS1 and INT1 obtained geometries for Ren:Angdodecapeptide:W1:W2 model 
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molecule. Also as in the previous mechanism the scissile bond stretches to 1.57Å, which 
means, again, that this bond has not been completely cleaved at this point and the products 
are not completely formed. Therefore, a third mechanistic step was performed. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction coordinate adopted is represented by the arrow between Asp226:H and Val11:N. A) Representation of the 
TS2 geometry. B) Representation of the INT2 geometry. The main interactions between the atoms in the active site are 
represented in the figure. Other interactions are represented in Table 3. 
 
4.4.4 The third reaction step 
Again, likewise the previous mechanism, a third reaction step was achieved in order to 
obtain the reaction products. The adopted reaction coordinate is represented in the in Figure 
Figure 19. TS2 and INT2 geometries obtained for Ren:Angdodecapeptide:W1:W2 model. 
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20A. During the scan the TS3 and P geometries were obtained. The TS3 active site 
geometry retains its overall structure and all interactions are similar to the previous 
mechanism. As the reaction proceeded the hydroxyl gem-diol proton (H1) was progressively 
transferred to Asp38, and the scissile bond spontaneously broke. The rearrangement of the 
active site residues was also similar to the earlier mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction coordinate adopted is represented by the arrow between Asp38:OD1 and gem-diol:H1. A) Representation of the 
TS3 geometry. B) Representation of the Product geometry. The main interactions between the atoms in the active site are 
represented in the figure. Other interactions are represented in Table 3. 
Figure 20. TS3 and Products geometries obtained for Ren:Angdodecapeptide:W1:W2 model. 
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In this QM/MM study, the influence of the structural water molecule on the catalytic 
mechanism of human renin has been investigated and its influence in the geometry of the 
active site residues seems to be insignificant. However, the present study does not measure 
the impact of the structural water molecule on the folding of the protein. Other studies 
suggest that this water is strategically placed to stabilize the conformation of the flap. The 
movement of the flap occurs in many aspartic proteases and this water molecule appears to 
be aiding in this mechanism. However the exact function of this water molecule is not fully 
understood, yet [45, 105].  
 
 
Table 3. Representation of the main interactions between the active residues and the residues around the active site 
during the reaction mechanism for Ren:Angdodecapeptide:W1:W2 model. 
Distances/Å R TS1 INT1 TS2 INT2 TS3 P 
Active Residues 
Leu10:C-W1:O 3.23 1.75 1.45 - - - - 
Asp38:OD2-Leu10:O 1.60 1.39 1.01 - - - - 
Asp228:OD2-W1 H1 2.02 1.66 1.02 - - - - 
Leu10:C-Val11:N - - - 1.54 1.57 1.59 3.80 
Asp226:HW1 -Val11:N - - - 1.20 1.07 1.06 1.04 
HAsp38-gemdiol-Asp32 - - - - - 1.35 1.02 
HW1-gemdiol-Asp215 - - - - - 1.63 1.01 
Residues around the active site 
Tyr83:H-W2:O 1.82 1.80 1.82 1.78 1.78 1.78 1.89 
W2:H-Ser41:O 1.86 1.91 1.87 1.84 1.85 1.87 1.94 
Ser41:H Asp38:OD2 1.87 1.80 1.67 1.72 1.73 1.75 1.81 
His9:H Asp226:OD2 1.74 1.82 2.05 1.95 1.82 1.81 1.85 
 
 
4.5 Human renin catalytic mechanism with a 
mutated substrate  
Preeclampsia is a common hypertensive disorder of pregnancy and it is associated with 
maternal, fetal and neonatal morbidity and mortality. Some studies have identified a 
mutation in angiotensinogen at the position 10 leading to the replacement of a Leu to a Phe, 
at the site of renin cleavage [91]. Due to the importance of this alteration, we also study the 
atomistic detail of the catalytic mechanism of human renin with mutated angiotensinogen.  
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4.5.1 The reactants structure 
The structure of the system is very similar to the first presented model. The only 
difference between these two structures lies in the substrate. At the position 10, a Leu 
residue was replaced by a Phe residue. The geometry of the new reactants is represented in 
Figure 21A. 
 
4.5.2 The first reaction step 
Once again, the strategy for the study of the first mechanistic step was the reaction 
coordinate between the catalytic water oxygen and the carbonyl carbon of the scissile bond. 
During the scan, along the reaction coordinate, the structure of the first TS was identified 
and it is represented in Figure 21B.  
 Identical to the previous mechanisms, the water molecule nucleophile attack is 
accompanied by a synchronized delivery of a proton from Asp38 to the oxygen of carbonyl 
group.  A detail analysis on TS1 geometry shows that the distance between the OW1 and 
Ccarbonyl decrease from 3.24Å in reactants structure to 1.70Å. About the residues around the 
active site, their structures are similar to the previous ones obtained in the other mechanism. 
In a general comparison between this TS geometry with the previous ones, it is possible to 
observe that with the mutated substrate, the distance between OW1 and Ccarbonyl, in TS1 
structure is little smaller than the previous ones. The H-bond between Tyr83 and Ser41 and 
is also smaller than the preceding structures. Although this specific differences, the 
remainder system is identical to the reaction with wild type substrate. The smaller distances 
are observed probably because Phe residue is a larger residue than Leu residue.  
The proton from Asp38 has been completely transferred to the carbonyl carbon at this 
first step like it happened in the reaction with wild type substrate. This first reaction step 
leads to the formation of a gem-diol intermediate, with a change in carbon hybridization from 
sp2 to sp3 and planar to tetrahedral respectively, as expected. The H-bonds between Asp38-
Ser41-Tyr83-Trp45 is also preserved as in reactants and there are no relevant alterations in 
main geometry when it is compared to the reaction with the wild type mechanism. 
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Figure 21. Reactants, TS1 and INT1 obtained geometries for Ren:AngMutated:model. 
A) Representation of the structure used as reactants. The adopted reaction coordinate is represented by the arrow between 
Leu10: C and W1:O. B) Representation of the TS1 geometry. At this step the W1:O is near Leu10:C. C) Representation of the 
gem-diol INT1 geometry. The main interactions between the atoms in the active site are represented in the figure. Other 
interactions are represented in Table 4. 
 
4.5.3 The second reaction step 
 In the second mechanistic step the adopted reaction coordinate was the distance 
between the amide nitrogen and the Asp226 proton, as in the previous studies. In the TS2 
geometry, the proton is located between this two residues and it only completely transferred 
in the INT2 structure.  
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In agreement with the reaction studied previously by us, and contrarily to other aspartic 
proteases, the scissile bond between de carbonyl carbon and amide nitrogen has not been 
cleaved yet and the proton from gem-diol has not been transferred back to the Asp38. In this 
structure, the catalytic Asp38 keeps their negative charge and the amide nitrogen gains a 
positive charge, in an analogous manner to the reaction with the wild type substrate. A third 
reaction step is also necessary for the cleavage of the mutated angiotensinogen. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
The reaction coordinate adopted is represented by the arrow between Asp226:H and Val11:N. A) Representation of the TS2 
geometry. B) Representation of the INT2 geometry. The main interactions between the atoms in the active site are represented 
in the figure. Other interactions are represented in Table 4. 
 
4.5.4 The third reaction step 
In this new step, the distance between the proton from the gem-diol hydroxyl and Asp38 
carboxyl oxygen, was used again as reaction coordinate. The geometry of the final products 
shows, again, a protonated catalytic dyad and two independent peptides, one with a 
charged carboxyl terminal group and another one with a neutral amine terminal, as it have 
been seen for the wild type substrate.  
These results show that the catalysis of the mutated substrate is similar to the natural 
substrate. With these results, it is possible to conclude that the alteration of a Leu residue by 
a Phe residue, in angiotensinogen sequence, does not change the mechanistic reaction in a 
structural perspective. These results showed that the mutated substrate could be cleaved 
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Figure 22. TS2 and INT2 geometries obtained for Ren:AngMutated:W1 model 
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likewise the wild type substrate and the presence of a different residues does not change 
the organization of the active site during the reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction coordinate adopted is represented by the blue arrow between Asp38:OD1 and Gem-diol:H1. A) Representation of 
the TS3 geometry. B) Representation of the Product geometry with formation of two peptides. The main interactions between 
the atoms in the active site are represented in the figure. Other interactions are represented in Table 4. 
 
Table 4. Representation of the main interactions between the active residues and the residues around the active site 
during the reaction mechanism for Ren:Angdodecapeptide:mutated model 
Distances/Å R TS1 INT1 TS2 INT2 TS3 P 
Active Residues 
Phe10:C-W1:O 3.24 1.70 1.44 - - - - 
Asp38:OD2-Leu10:O 1.62 1.35 1.00 - - - - 
Asp228:OD2-W1 H1 2.07 1.57 1.00 - - - - 
Leu10:C-Val11:N - - - 1.52 1.57 1.61 3.76 
Asp226:HW1 -Val11:N - - - 1.30 1.08 1.06 1.04 
HAsp38-gemdiol-Asp32 - - - - - 1.25 1.02 
HW1-gemdiol-Asp215 - - - - - 2.98 1.01 
Residues around the active site 
Tyr83:H-Ser41:O 2.48 2.18 2.27 2.09 2.12 2.20 2.05 
Ser41:H Asp38:OD2 1.85 1.81 1.70 1.73 1.75 1.79 1.84 
His9:H Asp226:OD2 1.75 1.86 2.09 2.06 1.86 1.81 1.86 
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Figure 23. TS3 and Products geometries obtained for Ren:AngMutated:W1 model. 
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4.6 Energies associated with human renin 
mechanistic pathway 
 
 The ONIOM energies were calculated along the reaction coordinate and the higher 
energies were associated with the Transition states geometries. 
 As we saw in the geometries description, according our  calculations, the mechanism of 
human renin occurs through three reaction steps, while the mechanism of other aspartic 
protease (such as HIV-1 protease, β-secretase [50, 93]) occurs by two steps. The second 
step is characterized by the amide nitrogen protonation simultaneous with the protonation of 
deprotonated Asp residue and peptide bond cleavage, which was not observed in our 
results. 
 In this section, the energies associated with stationary points of human renin reaction 
will be presented and compared with available experimental data for this catalytic 
mechanism. Then the results of single point energy calculation, with large QM models, 
performed in order to include the influence of other residues in the energy associated with 
each reaction step, will be discussed. 
 
4.6.1  Energies along the reaction mechanism2 
 
4.6.1.1 Ren:Angdodecapetide:W1 model 
 For the mechanism related to the first model, the calculated activation barrier for 
formation of the gem-diol intermediate, during the scan, was 27.2 kcal.mol-1. This step was 
endergonic by 11.9 kcal.mol-1. The second mechanistic step was characterized by activation 
energy of 29.2 kcal.mol-1 and it was also endergonic by 25.7 kcal.mol-1. Finally, for the third 
mechanistic step, the calculated activation energy has a value of 26.3 kcal.mol-1.Our 
calculations showed a global exergonic mechanism by -11.6 kcal.mol-1 (Figure 24). 
                                               
 
 
2
 All energy values presented in this section correspond to relative energies (energy of reactants are defined as zero). 
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The experimental activation barrier obtained for the recombinant human renin, with 
recombinant human angiotensinogen, and with angiotensionogen terminal tetradecapeptide, 
obtained by previous studies, are 17.6 kcal.mol-1 (kcat = 1.41s
-1) and 16.5 kcal.mol-1 (kcat = 
8.1s-1), respectively [106]. The comparison of the experimental and computational data 
shows a significant difference between the described values. The energies were taken 
directly from the scan and the values represent enthalpy barriers instead of the activation 
Gibbs energies, which could partially explain the observed differences.   
 
 
 
 
 
 
 
 
 
 
 
Barriers for this reaction were calculated at B3LYP/6-31G(d)//AMBER level and the energies are represented in  kcal.mol
-1
. 
 
4.6.1.2 Ren:Angdodecapetide:W1:W2 model 
 For the second model mechanism the formation of a gem-diol intermediate was 
associated to 29.0 kcal.mol-1 and this first step was endergonic by 12.1 kcal.mol-1. The 
formation of the second intermediate is associated with a value of 23.9 kcal.mol-1 and the 
second mechanism was endergonic by 18.6 kcal.mol-1. The activation barrier for the 
formation of the third TS was 17.9 kcal.mol-1 and overall reaction is exergonic by -21.7  
kcal.mol-1 (Figure 25). It is important to compare the energies obtained for the two models. 
The presence of structural W2 does not seem to have a big influence in the reduction of the 
relative reaction energies. The first reaction step had a larger relative energetic value in the 
presence of the W2. However, the second transition state is stabilized by the presence of 
this molecule, because it was associated with a low barrier. It is also important to refer that 
with the presence of W2 the catalytic reaction leads to more stable products. However, 
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B3LYP/6-31G(d) -  Mechanical embedding 
Figure 24. Energetic pathway for angiotensinogen hydrolysis - Ren:Angdodecapeptide:W1 model 
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R TS1 INT1 TS2 INT2 TS3 P
Ren:Ang:W1 0.0 27.2 11.9 29.2 25.7 26.3 -11.6
Ren:Ang:W1:W2 0.0 29.0 12.4 23.9 18.6 18.6 -21.7
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B3LYP/6-31G(d) -  Mechanical embedding 
Figure 25. Energetic pathway for angiotensinogen hydrolysis – Ren:Angdodecapeptide:W1:W2 model  
 
when we compare these energies with the experimental ones, the activation barrier 
continues very high. These results show that the presence of the W2 is not essential for the 
occurrence of the angiotensinogen hydrolysis. In that way, the role of this molecule remains 
unknown.   
 
 
 
 
 
 
 
 
 
 
 
   
Barriers for this reaction were calculated at B3LYP/6-31G(d)//AMBER level and the energies are represented in  kcal.mol
-
1
.Orange line corresponds to the energetic pathway for Ren:Angdodecapeptide:W1:W2 and grey line corresponds to the energetic 
pathway for Ren:Angdodecapeptide:W1. 
 
4.6.1.3 Ren:AngMutated  model 
 In the third model the activation barrier associated with the formation of gem-diol 
intermediate was 20.9 kcal.mol-1. This first step was endergonic by 4.6 kcal.mol-1. The 
second step had an activation barrier of 14.8 kcal.mol-1 and it is also endergonic with 12.7 
kcal.mol-1 as associated energy. The activation barrier for the third TS was 12.9 kcal.mol-1. 
This mechanism is also exergonic and leads to a very stable product (-29.5 kcal.mol-1) 
(Figure 26). 
Previous studies have shown an invariance of the cleavage site in a renin reaction with 
Leu10Phe mutated substrate. Furthermore they showed that the catalytic efficiency of renin 
reaction, measured as the ratio kcat/Km, was higher for mutant substrate than for wild-type 
substrate [91]. The experimental activation barrier for this reaction, with the angiotensinogen 
terminal tetradecapeptide, is 18.3 kcal.mol-1. This value is similar to the energy obtained in 
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this work. However, the energies obtained for the mutated substrate mechanism should be 
higher than the energies obtained for the wild type mechanism and this did not happened. 
 
 
 
 
 
 
 
 
 
 
 
 
Barriers for this reaction were calculated at B3LYP/6-31G(d)//AMBER level and the energies are represented in kcal.mol
-1
.Pink 
line corresponds to the energetic pathway for Ren:AngMutated and grey line corresponds to the energetic pathway for 
Ren:Angdodecapeptide:W1. 
 
4.6.2 Single Point energy calculations 
4.6.2.1 Single point calculations using electrostatic embedding 
scheme 
As the first two presented mechanisms have been quite similar, the results for the first 
model was used to performed single point calculations to recalculate the energies in the 
stationary points, using the electrostatic embedding scheme. First, it was used B3LYP/6-
31G(d) level to treat the QM region and electrostatic embedding scheme was used to treat 
the QM/MM boundary interactions. 
The activation barrier for the formation of the first TS was 17.1 kcal.mol-1 (a decrease of 
about 10 kcal.mol-1 in comparison with the energy obtained with mechanical embedding). 
This new calculation indicates that the first reaction step is endergonic only by 2.2 kcal.mol-1. 
The second mechanistic step are characterized by and activation barrier of 9.7 kcal.mol-1 
and is also endergonic by 6.1 kcal.mol-1. The third mechanistic step was characterized by 
R TS1 INT1 TS2 INT2 TS3 P
Ren:Ang:W1 0.0 27.2 11.9 29.2 25.7 26.3 -11.6
Ren:AngMut 0.0 20.9 4.6 14.8 12.7 12.9 -29.5
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B3LYP/6-31G(d) -  Mechanical embedding 
Figure 26. Energetic pathway  for angiotensinogen hydrolysis - Ren:AngMutated model 
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6.9 kcal.mol-1 and the relative energy associated to the products was -18.3 kcal.mol-1 (Figure 
27). As said before, in mechanical embedding scheme the interactions between the two 
subsystems are included in the force field level and the MM environment cannot induce 
polarization in the QM region. On the other hand, in the electrostatic embedding scheme the 
electrostatic interactions between the two subsystems are handled at the DFT level and their 
influence in the polarization of the QM subsystem is included. In that way, with the obtained 
results, we can conclude that the influence of the MM residues in the QM region should be 
very important in the human renin catalytic mechanism. 
Barriers for this reaction were calculated at B3LYP/6-31G(d)//AMBER level and the energies are represented in kcal.mol
-1
. 
 
4.6.2.2 Single point calculation using large QM regions 
As mentioned before, in order to include the influence caused by residues around the 
active site in the energetic calculations, the QM region was expanded in a progressive way 
(spherical shells centered in the catalytic water molecule) and the energies were 
recalculated. 
In the first model, only Leu10 and Val10 remainder lateral chains was added to 
stationary points and the QM region was increase from 33 atoms to 55 atoms.  
The energy was recalculated at B3LYP/6-31G(d) level with electrostatic embedding 
scheme. The calculated activation barrier for the first mechanistic step formation was 13.9 
kcal.mol-1 and contrarily to the previous calculations, the first reaction step was 
characterized by -3.8 kcal.mol-1 relative energy (exergonic). The calculated activation barrier 
for the formation of the second TS was 8.9 kcal.mol-1 and this step was endergonic by 8.2 
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Figure 27. Single point calculation with B3LYP 6-31G(d) level and electrostatic embedding scheme. 
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R TS1 I1 TS2 I2 TS3 P
33 Atoms 0.0 17.1 2.2 9.7 6.1 6.9 -18.3
55 Atoms 0.0 13.9 -3.8 8.9 8.2 11.5 -6.7
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kcal.mol-1. For the third reaction step, the calculated activation barrier was 11.5 kcal.mol-1 
and the formation of the products is associated with -6.7 kcal.mol-1 relative energy (Figure 
28). 
 
 
 
 
 
 
 
 
 
 
 
 
A) Representation of the high layer residues. B) Energetic pathway along the reaction (green representation).  
 
In a second model His9, Ser38 and Tyr83 was added to the previous model. This 
system has 100 atoms in the high layer. The calculated activation barrier for the first TS was 
9.2 kcal.mol-1 and this step was exergonic by -4.2 kcal.mol-1.The second TS had an 
activation barrier of 10.2 kcal.mol-1 and the reaction step is endergonic by 9.8 kcal.mol-1. The 
calculated barrier for third TS was 11.4 kcal.mol-1 and product formation is associated with -
15.3 kcal.mol-1 relative energy (Figure 29). 
 
 
 
 
 
 
 
 
 
  
 
A) Representation of the high layer residues. B) Energetic pathway along the reaction (blue representation). 
 
In a third model Gly40, Ser84, Gly217 and Ala218 were added to the previous model. 
This new model has 135 atoms in the QM region. The calculated activation barrier for the 
Figure 28. Single Point QM/MM calculations for a model with 55 atoms in high layer. 
Figure 29. Single Point QM/MM calculations for a model with 100 atoms in high layer 
B A 
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R TS1 I1 TS2 I2 TS3 P
100Atoms 0.0 9.2 -4.2 10.2 9.8 11.4 -15.3
135 Atoms 0.0 14.3 -2.0 5.3 4.5 7.0 -12.2
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Electrostatic Embedding 
A B 
first TS was 13.1 kcal.mol-1 and this first step is exergonic by -2.0 kcal.mol-1. The second TS 
had an activation barrier of 5.3 kcal.mol-1 and it is endergonic by 4.5 kcal.mol-1. The third TS 
is associated with 7.0 kcal.mol-1 and the formation of the products is exergonic by -12.2 
kcal.mol-1 (Figure 30). 
 
 
 
A) Representation of the high layer residues. B) Energetic pathway along the reaction (violet representation). 
 
We have tested also the influence of other atoms around the active site (Thr36, Val121, 
Leu213, Val214 and Thr216). This new system has 210 atoms in the high layer. The 
calculated activation barrier for the first TS was 13.1 kcal.mol-1 and this mechanistic step 
was exergonic by -2.9 kcal.mol-1.  
 
 
 
 
 
 
 
 
 
 
 
 
A) Representation of the high layer residues. B) Energetic pathway along the reaction (pink representation). 
 
Figure 30. Single Point QM/MM calculations for a model with 135 atoms in high layer 
 
Figure 31. Single Point QM/MM calculations for a model with 210 atoms in high layer 
 
R TS1 I1 TS2 I2 TS3 P
135 Atoms 0.0 14.3 -2.0 5.3 4.5 7.0 -12.2
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The second TS has an activation barrier of 8.8 kcal.mol-1 and it is very similar to the 
energy calculated for the second intermediate (9.0 kcal.mol-1). This results may indicate that 
this second TS cannot correspond to a real TS or it was not correctly optimized. The third 
TS has a barrier of 10.8 kcal.mol-1 and the formation of the products is exergonic by -6.9 
kcal.mol-1 (Figure 31). 
Finally we expand our system to 322 atoms in QM layer. This new model includes the 
Leu75, part of Arg76, Gly80, Val122, Lys247, Thr289 and Ile330. The first TS has a barrier 
of 13.8 kcal.mol-1 and is little exergonic by -0.9 kcal.mol-1. The second TS has a barrier of 
14.2 kcal.mol-1 and it is endergonic by 13.7 kcal.mol-1. The third TS has a barrier of 16.9 
kcal.mol-1 and the products formation is little endergonic by 0.5 kcal.mol-1 (Figure 32). 
 
 
 
 
 
 
 
 
 
 
 
A) Representation of the high layer residues. B) Energetic pathway along the reaction (orange representation). 
 
The comparison between all these models shows some differences between the 
presented results. First of all, when the electrostatic embedding scheme is included in our 
calculation, the energies associated with each stationary point decrease in comparison with 
the energies obtained in optimizations with mechanical embedding scheme. These results 
were expected because the inclusion of the MM atoms polarization effect on the QM atoms, 
allows a better description of the system. Furthermore, when the QM region was expanded 
the relative energies decrease again. This means that the residues around the active site 
have a meaningful influence in reaction energy. 
If we focus only in the first mechanistic step, which corresponds to the formation of the 
gem-diol intermediate, we can see that when the lateral chains of Val10 and Leu11 are 
included, the energetic barrier for the TS formation decrease about 3 kcal.mol-1, which can 
Figure 32. Single Point QM/MM calculations for a model with 322 atoms in high layer 
R TS1 I1 TS2 I2 TS3 P
210 Atoms 0.0 13.1 -2.9 8.8 9.0 10.8 -6.9
322 Atoms 0.0 13.8 -0.9 14.2 13.7 16.9 0.5
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be indicative that this lateral chains are important for this first reaction step. When we 
expand the QM region the energy associated to this first step keeps approximately constant 
between the tested models. This is indicative that, probably, this influence is confined to the 
residues that contribute directly on the reaction. 
However, the analysis of the second and third mechanistic steps shows some variances 
between the different models. These differences indicate that the added residues influence 
the energy associated with this second and third reactions. In the second step, the proton 
from Asp256 is transferred to the amide nitrogen of the scissile bond. Therefore, the Asp256 
residue has a negative charge, and the amine nitrogen has a positive charge. These 
charges should interact strongly with the residues around the active site, and they can justify 
the differences discussed above. 
 
4.6.2.3 Single point calculations with a large basis set 
Afterwards the energies were recalculated at the B3LYP/6-311++G(2d,2p) level, also 
with the electrostatic embedding scheme. This large basis set was used to include the 
dispersive and polarization effects on the single point energy calculation. 
Using the initial QM region (33 atoms), the results indicated an energetic barrier of 20.7 
kcal.mol-1 associated with the first TS and 6.6 kcal.mol-1 for the first mechanistic step. The 
second mechanistic step was also endergonic by 11.8 kcal.mol-1 with 15.7 kcal.mol-1 
associated with the second TS formation. The barrier associated with the third mechanistic 
step was 12.6 kcal.mol-1 and the formation of the products was exergonic by 16.0  kcal.mol-1 
(Figure 33 – grey representation). 
In the model with 55 atoms in the QM region, the energetic barrier for the formation of 
the first TS was 17.4 kcal.mol-1 and the first TS is little endergonic by 0.7 kcal.mol-1. The 
second and third transition states are associated with 15.0 kcal.mol-1 and 17.2 kcal.mol-1, 
respectively and the reaction is exergonic by 3.3 kcal.mol-1 (Figure 33 – green 
representation). 
In the model with 100 atoms in QM region, the first TS is associated with a barrier of 
14.1 kcal.mol-1. The second and third transition states are associated with 17.6 kcal.mol-1, 
and 18.3 kcal.mol-1 respectively. The reaction is exergonic by -11.3 kcal.mol-1 (Figure 33 – 
blue representation). 
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In the model with 135 atoms, the first TS is associated with an energetic barrier of 20.0 
kcal.mol-1. The second and third transition states have a barrier of 11.2 kcal.mol-1 and 12.2 
kcal.mol-1. The reaction is exergonic by 8.9 kcal.mol-1 (Figure 33 – violet representation). 
The other two models (with 210 atoms and 322 atoms in high layer) were not tested 
because of the computational power that they need.   
With these results it is possible to affirm that the first step of the reaction is probably the 
limiting one and the other two steps have very similar energies.  
 
 
 
 
 
 
 
 
 
The different colors represent the different models with 33, 55,100 and 135 atoms in high layer. The relative energies are 
represented in kcal.mol
-1
and they were obtained with single point energy calculation at B3LYP/6-311++G(2d,2p)//Amber level. 
 
This increase of the QM models was intended to include the effects of residues around 
the active center in the energy calculation for the stationary points. Even though much of the 
energy values calculated for reaction activated barrier stand at around 17-20   kcal.mol-1, 
which is quite similar to the experimental energy associated with renin mechanism, there is 
some lack of agreement between the different studied models. Such observation may be 
due to the fact that the geometries of the stationary states have been taken directly from the 
PES scan and they are only approximate geometries for TS and INT points of the reaction. 
Probably they don’t correspond to the very precise TS or INT and they require a re-
optimization of the structure. Another explanation to these differences lies in the fact that the 
Figure 33. Single Point QM/MM calculations with a large basis set (6-311++G(2d,2p)) 
 
R TS1 I1 TS2 I2 TS3 P
33 Atoms 0.0 20.7 6.6 15.7 11.8 12.6 -16.0
55 Atoms 0.0 17.4 0.7 15.0 14.0 17.2 -3.3
100 Atoms 0.0 14.1 0.2 17.6 17.2 18.3 -11.3
135 Atoms 0.0 20.0 3.8 11.2 10.5 12.2 -8.9
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added residues were previously optimized with MM and molecular embedding scheme, 
during the PES scan, and they were not re-optimized within the new level of theory.  
The increasing of the QM model, only for energy calculations, requires considerable 
attention, not only in the choice of the added atoms, but also in the methods and in the 
interpretation of the results. However it is useful to understand the influence of the residues 
around the active site in a given catalytic reaction.  
It is also important to note that the energetic problems observed in this study may also 
be due to the initial conformation of the enzyme. If a different initial conformation had been 
chosen as initial conformation, the calculated energy barriers could be different. 
 
4.7 Human Renin vs. Mouse Renin 
As mentioned previously, the mouse renin catalytic mechanism was previous described 
by our group [4]. The methodology used in these work was similar to those used in the 
present work. According to previous studies there are few differences between mouse renin 
and human renin. These two enzymes have about 68% of sequence identity [107] and they 
have similar folds and similar active site residues [108].  
Mouse is the usual animal model to test new drugs and, therefore, it is very important to 
compare the mouse renin mechanism with human renin mechanism, in order to understand 
if the studies in mice are transferable to humans. 
The comparison of mouse and human renin has revealed that these two enzymes have 
similar catalytic mechanism. The results of mouse renin work showed that the renin’s 
mechanism of action proceeds through three mechanistic steps. First, the water molecule 
performs a nucleophilic attack to the carbonyl carbon of the scissile bond generating a gem-
diol intermediate. In the second step the catalytic Asp residue (protonated in the previous 
step), protonates the amide nitrogen of the scissile bond, and only in a third step the 
cleavage of the peptide bond occurs, leading to the formation of two separate peptides. The 
results described in the present work have shown that human renin cleaves its substrate by 
the three same reaction steps. Furthermore the geometries of the stationary points 
(transition states, intermediates and products) for mouse and human renin were similar 
during all reaction.  
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 These results show that both human and mouse enzymes appear to cleave the 
substrate by the same mechanism and with the same geometries along the reaction. 
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CHAPTER 5  
CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
5.1 Conclusions 
Throughout this work we were able to describe the reaction path for angiotensinogen 
hydrolysis by human renin, with atomistic detail. The obtained results showed that this 
mechanism occurs by three steps, contrarily to other aspartic proteases. First, the enzyme 
activates the catalytic water molecule, which performs a nucleophile attack to the carbonyl 
carbon of the scissile angiotensinogen bond. This attack is accompanied by the 
deprotonation of the water molecule by Asp226 and, simultaneously by the protonation of 
the carbonyl oxygen by Asp38, generating a gem-diol intermediate. In the second step, 
Asp226 protonates the amide nitrogen of the substrate scissile bond. At this stage, this bond 
is weakened and elongated; however it only breaks in the third and last reaction step. In this 
last step, Asp38 deprotonates a hydroxyl group of the gem-diol and, simultaneously the 
other hydroxyl group is deprotonated by the other catalytic Asp residue. The human renin 
reaction leads, therefore, to the formation of two separate peptides, as well as two 
protonated catalytic aspartate residues.  
It is also possible to conclude that the first mechanistic step of the hydrolysis reaction is 
rate limiting and it has an activation barrier of 20.0 kcal.mol-1 at B3LYP/6-
311++G(2d,2p):Amber level of theory, with 135 atoms in high layer, which was the result 
obtained with the best theoretical level. This value is comparable with the experimental one 
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for the angiotensinogen terminal tetradecapeptide which is 16.5 kcal.mol-1. The differences 
observed between the values, may be due to the fact that we use a dodecapeptide instead 
of a tetradecapeptide as substrate. Furthermore, single point energy calculations were used 
to re-calculate the energy associated with each stationary point, instead of a re-optimization 
of the structures with the new theoretical level, which may also have some influence on the 
obtained values. Additionally only an initial conformation was studied, instead of different 
initial conformations. 
The comparison of the results obtained with electrostatic embedding and mechanical 
embedding schemes shows that the first provides a better description of the energetic profile 
of human renin reaction.  
The obtained results also allow us to conclude that the structural water molecule, which 
is common in the most aspartic proteases, seems to be indifferent to the rearrangement of 
the active site during the renin catalytic mechanism. 
With this work it was also possible to conclude that the catalysis of the mutated 
substrate (Leu10Phe) appears to be quite similar to the catalysis of the natural substrate.  
Accordingly, we can state that the association of preeclampsia to this mutation should not be 
explained by a change in the catalytic mechanism of the enzyme and it must be due to 
another reason. 
Research on the renin catalytic mechanism is essential because this enzyme has an 
important role in the blood pressure control. The description of its mechanism of action and 
its transition states structures are the key for anti-hypertensive rational drug design. The 
transition state geometry can be taken as a template for the search of new transition-state 
analogues inhibitors. Such geometry is very difficult to obtain by experimental works, and 
because of it, the computational works are essential in this area.  
This QM/MM study allows for a complete atomistic comprehension of renin catalytic 
mechanism and it may be useful to improve the efficiency of anti-hypertensive drug design. 
 
5.2 Future Perspectives 
With the results obtained in this work, it was possible to describe the catalytic 
mechanism of human renin. Last year, our group has published an article describing the 
catalytic mechanism of mouse renin. However, until now, there were no solid works 
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describing the catalytic mechanism of human renin. In order to clarify the detail of this 
mechanism, a paper with the results obtained in this work, is being prepared. 
In attempt to improve the results obtained in this work, especially in terms of energy, the 
stationary points could be re-optimized without constraints. The structures obtained from this 
sort of optimization could be used to calculate vibrational frequencies, in order to compute 
zero-point vibration and entropic and thermal energy corrections to total energies.  
In addition, the mechanism could be repeated using electrostatic embedding scheme 
and with different initial conformations, in order to compare with the obtained results. 
Furthermore an optimization of the models with large QM layers could improve the 
calculated energies, and probably it decreases the differences observed between the 
different models.  
Although there are still issues for improvement, the information contained in this work is 
very important for the comprehension of renin catalytic mechanism and for the rational 
design of new renin inhibitors.  
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